w. ray kim - stanford university

of 32

W. Ray KimProfessor of Medicine (Gastroenterology and Hepatology)

Medicine - Gastroenterology & HepatologyNIH Biosketch available Online

CLINICAL OFFICES

• Stanford Gastroenterology and Digestive Health Clinic

450 Broadway St

Pav D 2nd Fl Pod 2 and 3

Redwood City, CA 94063

Tel (650) 498-7999 Fax (650) 724-9454

• Liver Transplant Clinic

300 Pasteur Dr A160

MC 5309

Stanford, CA 94305

Tel (650) 498-7878 Fax (650) 498-7888

ACADEMIC CONTACT INFORMATION

• Administrative Contact

Bobby Esquivel - Administrative Associate

Email [email protected]

Tel 650-725-6511

Bio

BIO

Chronic liver disease is one of the most common causes of premature death in Americans. My career goal is to improve the outcome of individuals with chronic liver

disease by identifying the optimal means for diagnosis, monitoring, treatment and prevention. The path I have chosen to achieve this goal is through engagement in

clinical epidemiology and patient-oriented, effectiveness research.

Since the development of the MELD score which recognizes the importance of renal function in the prognosis of patients with end stage liver disease, one of the

areas that we have had intense interest has been acute and chronic renal injury in patients undergoing liver transplantation. Liver transplantation represents a unique

opportunity for research, because of the potential for reversal of the renal injury as well as access to biological materials.

CLINICAL FOCUS

• Liver Cirrhosis

• Hepatitis C

• Gastroenterology

• Hepatitis B, Chronic

• Hepatology

• Liver Transplantation

ACADEMIC APPOINTMENTS

• Professor - University Medical Line, Medicine - Gastroenterology & Hepatology

W. Ray Kimhttp://cap.stanford.edu/profiles/W._Kim/

of 32

ADMINISTRATIVE APPOINTMENTS

• Chief, Division of Gastroenterology & Hepatology, Department of Medicine, Stanford Unversity, (2013- present)

BOARDS, ADVISORY COMMITTEES, PROFESSIONAL ORGANIZATIONS

• Treasurer, AASLD (2014 - 2017)

• Chair, Development Committee, AASLD (2011 - 2014)

• Senior Fellow, Center for Innovation in Global Health (2015 - present)

• Chair, Clinical Research Committee, AASLD (2008 - 2011)

• Associate Editor, Hepatology (2008 - 2011)

• Member, American Gastroenterological Association (1994 - present)

• Member, AASLD (1994 - present)

• Member, American College of Gastroenterology (1994 - present)

• Member, International Liver Transplant Society (1998 - present)

• Member, American Society for Transplant Physicians (1998 - present)

PROFESSIONAL EDUCATION

• Fellowship: Mayo Graduate School of Medicine (1998) MN

• Fellowship: Mayo Graduate School of Medicine (1997) MN

• Residency: University of Arkansas for Medical Sciences Medical Center (1994) AR

• Professional Education: University of Pennsylvania (1992) PA

• Residency: Seoul National University Hospital (1990)

• Internship: Seoul National University Hospital (1987)

• Medical Education: Seoul National University (1986)

• Board Certification: Gastroenterology, American Board of Internal Medicine (1998)

• M.B.A., Wharton School, University of Pennsylvania , Health Care Administration (1992)

• M.Sc., Seoul National University , Clinical Research (1990)

• M.D., Seoul National University , Medicine (1986)

Research & Scholarship

CLINICAL TRIALS

• The Effect of Branched-chain Amino Acid on the Improvement of Serum Albumin Level in Cirrhotic Patients With Ascites, Recruiting

• Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis, Not Recruiting

Teaching

GRADUATE AND FELLOWSHIP PROGRAM AFFILIATIONS

• Gastroenterology & Hepatology (Fellowship Program)

Publications

PUBLICATIONS

• Correcting the sex disparity in access to liver transplantation - Lest perfect be the enemy of better. American journal of transplantation : official journal ofthe American Society of Transplantation and the American Society of Transplant Surgeons


of 32

Kwong, A. J., Lai, J. C., Kim, W. R.

2021

• Diagnosis, evaluation, and management of ascites and hepatorenal syndrome. Hepatology (Baltimore, Md.)

Biggins, S. W., Angeli, P., Garcia-Tsao, G., Gines, P., Ling, S., Nadim, M. K., Wong, F., Kim, W. R.

2021

• Feasibility and Effectiveness of Norepinephrine Outside the Intensive Care Setting for Treatment of Hepatorenal Syndrome. Liver transplantation : officialpublication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Kwong, A., Kim, W. R., Kwo, P. Y., Wang, U., Cheng, X.

2021

• An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign-Born Persons Living in the United States. Hepatology (Baltimore, Md.)

Wong, R. J., Brosgart, C. L., Welch, S., Block, T., Chen, M., Cohen, C., Kim, W. R., Kowdley, K. V., Lok, A. S., Tsai, N., Ward, J., Wong, S. S., Gish, et al

2021

• Usefulness of Controlled Attenuation Parameter and Liver Stiffness Measurement for the Identification of Extended-criteria Donors and Risk-assessmentin Liver Transplantation. Transplantation

Duarte-Rojo, A., Heimbach, J. K., Borja-Cacho, D., Barone, G. W., Shaheen, M. F., Lamps, L. W., Graham, R. P., Tan, E. K., Concepcion, W., Kim, W. R.

2021

• OPTN/SRTR 2019 Annual Data Report: Liver. American journal of transplantation : official journal of the American Society of Transplantation and theAmerican Society of Transplant Surgeons

Kwong, A. J., Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., Noreen, S. M., Foutz, J., Booker, S. E., Cafarella, M., Snyder, J. J., Israni, A. K.,Kasiske, et al

2021; 21 Suppl 2: 208–315

• Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation. Hepatology communications

Alshuwaykh, O. n., Kwong, A. n., Goel, A. n., Cheung, A. n., Dhanasekaran, R. n., Ahmed, A. n., Daugherty, T. n., Dronamraju, D. n., Kumari, R. n., Kim, W. R.,Nguyen, M. H., Esquivel, C. O., Concepcion, et al

2021; 5 (3): 516–25

• Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease. Hepatology (Baltimore, Md.)

Singal, A. K., Kwo, P., Kwong, A., Liangpunsakul, S., Louvet, A., Mandrekar, P., McClain, C., Mellinger, J., Szabo, G., Terrault, N., Thursz, M., Winder, G. S.,Kim, et al

2021

• MELD 3.0: The Model for End-stage Liver Disease Updated for the Modern Era. Gastroenterology

Kim, W. R., Mannalithara, A., Heimbach, J. K., Kamath, P. S., Asrani, S. K., Biggins, S. W., Wood, N. L., Gentry, S. E., Kwong, A. J.

2021

• Methodological Challenges in Meta-Analysis to Assess the Risk of Hepatocellular Carcinoma Across Chronic Hepatitis B Treatments. Journal ofhepatology

Choi, W. M., Yip, T. C., Lim, Y. S., Wong, G. L., Kim, W. R.

2021

• Predicting survival after liver transplant: A noble pursuit or a fool's errand? Liver transplantation : official publication of the American Association for theStudy of Liver Diseases and the International Liver Transplantation Society

Kwong, A. J., Kim, W. R.

2021

• Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation HEPATOLOGY COMMUNICATIONS

Alshuwaykh, O., Kwong, A., Goel, A., Cheung, A., Dhanasekaran, R., Ahmed, A., Daugherty, T., Dronamraju, D., Kumari, R., Kim, W., Esquivel, C. O.,Concepcion, W., Melcher, et al

2020

• RISK OF INCIDENT HEPATOCELLULAR CARCINOMA (HCC) IN CHRONIC HEPATITIS B (CHB) VIRUS-INFECTED PATIENTS TREATEDWITH TENOFOVIR DISOPROXIL FUMARATE (TDF) VERSUS ENTECAVIR (ETV): A US ADMINISTRATIVE CLAIMS ANALYSIS

Kim, R., Telep, L., Lu, M., Ramroth, H., Flaherty, J., Gaggar, A., Chokkalingam, A., Chan, C., Gordon, S.

BMJ PUBLISHING GROUP.2020: A73


of 32

• HEPATITIS C SCREENING IN POST-BABY BOOMER GENERATION AMERICANS: ONE SIZE DOES NOT FIT ALL

Sriponapun, P., Kim, W., Udompap, P., Mannalithara, A., Kwong, A. J., Goel, A., Kwo, P. Y.

WILEY.2020: 590A

• MELD 3.0: AN UPDATED VERSION OF THE MODEL FOR END-STAGE LIVER DISEASE TO OPTIMIZE WAITLIST OUTCOMES IN THEMODERN ERA

Kim, W., Mannalithara, A., Kamath, P. S., Heimbach, J., Asrani, S. K., Biggins, S. W., Kwong, A. J.

WILEY.2020: 824A

• A MACHINE LEARNING MODEL TO SAFELY TRIAGE LOW-RISK NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS: THE STEATOSIS-ASSOCIATED FIBROSIS ESTIMATOR (SAFE) SCORE

Sripongpun, P., Mannalithara, A., Kim, D., Kim, W.

WILEY.2020: 888A–889A

• FEASIBILITY AND EFFICACY OF NOREPINEPHRINE IN THE NON-ICU SETTING FOR TREATMENT OF HEPATORENAL SYNDROME

Kwong, A. J., Cheng, X., Kwo, P. Y., Wang, U., Kim, W.

WILEY.2020: 1106

• THE PERVASIVE IMPACT OF PRURITUS ON QUALITY OF LIFE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC): REALWORLD EXPERIENCE IN TARGET-PBC

Carey, E. J., Smith, H., McLaughlin, M., Thompson, A., Mospan, A., Sandefur, R. A., Zink, R. C., Kim, W., Levy, C.

WILEY.2020: 766A–767A

• EARLY ALBUMIN INFUSION LEADS TO LOWER HOSPITALIZATION COSTS IN PATIENTS WITH CIRRHOSIS AND SPONTANEOUSBACTERIAL PERITONITIS: REAL EVIDENCE IN THE UNITED STATES

Kim, W., Raghunathan, K., Martin, G. S., Davis, E., Sindhwani, N., Telang, S., Lodaya, K.

WILEY.2020: 1120

• OUTCOMES AFTER HOSPITALIZATION WITH ACUTE DECOMPENSATION DUE TO ALCOHOL-RELATED LIVER DISEASE

Kwong, A. J., Goel, A., Daugherty, T., Kwo, P. Y., Kim, W.

WILEY.2020: 181A–182A

• THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B VIRUS INFECTION SUBJECTS NOT MEETINGCRITERIA FOR ANTIVIRAL THERAPY

Alshuwaykh, O., Goel, A., Daugherty, T., Cheung, A., Kim, W., Kwong, A. J., Ahmed, A., Ghaziani, T., Torok, N. J., Nguyen, M. H., Dronamraju, D.,Dhanasekaran, R., Kumari, et al

WILEY.2020: 472A–473A

• Clinical Response to Treatment for Acute Kidney Injury (AKI) in Patients With Cirrhosis

John, N., Alshuwaykh, O., Goel, A., Ahmed, A., Cheung, A., Dronamraju, D., Kumari, R., Daugherty, T., Dhanasekaran, R., Kim, R. W., Nguyen, M. H., Kwo, P.Y.

LIPPINCOTT WILLIAMS & WILKINS.2020: S587–S588

• Characterizing Ascites in Subjects With Nonhepatic Solid Tumors

Alshuwaykh, O., Cheung, A., Goel, A., Dhanasekaran, R., Ahmed, A., Dronamraju, D., Daugherty, T., Kim, R. W., Kumari, R., Torok, N., Ghaziani, T., Kwo, P. Y.

LIPPINCOTT WILLIAMS & WILKINS.2020: S507

• Center variation in intention to treat survival among patients listed for liver transplant. Liver transplantation : official publication of the AmericanAssociation for the Study of Liver Diseases and the International Liver Transplantation Society

Kwong, A. J., Flores, A., Saracino, G., Boutte, J., McKenna, G., Giuliano, T., Bahirwani, R., Wall, A., Kim, W. R., Klintmalm, G., Trotter, J. F., Asrani, S. K.

2020

• Prevalence of Chronic Hepatitis B Virus Infection in the United States. The American journal of gastroenterology

Lim, J. K., Nguyen, M. H., Kim, W. R., Gish, R., Perumalswami, P., Jacobson, I. M.

2020

• HEPATITIS B TREATMENT PATTERNS IN US CLINICAL CARE FOLLOWING TENOFOVIR ALAFENAMIDE (TAF) APPROVAL

Curry, M., Bae, H., Dieterich, D., Ankoma-Sey, Reddy, R., Pan, C., Hann, H. W., Tong, M., Kim, W. R., Kwo, P., Frazier, L., Cox, K., Milligan, S., et al

ELSEVIER SCIENCE INC.2020: S169

• Introducing the Smartphone App, EL-FIT (Exercise & Liver FITness), to Help Monitor and Prehabilitate Liver Transplant Candidates


of 32

Duarte-Rojo, A., Bloomer, P. M., Rogers, R. J., Dunn, M. A., Tapper, E. B., Bataller, R., Hughes, C. B., Ferrando, A. A., Kim, W. R., Jakicic, J. M.

WILEY.2020: 514

• National Trends in Locoregional Therapy among Liver Transplant (LT) Candidates with Hepatocellular Carcinoma (HCC) in the United States

Kwong, A., Kim, W., Yao, F., Mehta, N.

WILEY.2020: 490–91

• Creating a Patient Website to Search for Transplant Centers: www. transplantcentersearch.org

Schaffhausen, C. R., Chu, S., Bruin, M., Matas, A., Hertz, M., Martin, C., Lake, J., Kim, W., Biggins, S., Snyder, J. J., Kasiske, B. L., Israni, A. K.

WILEY.2020: 555

• Exercise-Induced Hyperammonemia Does Not Precipitate Overt Hepatic Encephalopathy. Hepatology (Baltimore, Md.)

Lin, F., Ferrando, A. A., Dennis, R. A., Dunn, M. A., Kim, W. R., Duarte-Rojo, A.

2020

• Home-Based Physical Activity and Diet Intervention to Improve Physical Function in Advanced Liver Disease: A Randomized Pilot Trial. Digestivediseases and sciences

Chen, H. W., Ferrando, A., White, M. G., Dennis, R. A., Xie, J., Pauly, M., Park, S., Bartter, T., Dunn, M. A., Ruiz-Margain, A., Kim, W. R., Duarte-Rojo, A.

2020

• Tool to aid patients in selecting a liver transplant center. Liver transplantation : official publication of the American Association for the Study of Liver Diseasesand the International Liver Transplantation Society

Schaffhausen, C. R., Bruin, M. J., Chu, S. n., Fu, H. n., McKinney, W. T., Schladt, D. n., Snyder, J. J., Kim, W. R., Lake, J. R., Kasiske, B. L., Israni, A. K.

2020

• Overview of Current and Emerging Treatments for Hepatitis B Virus Infection. Gastroenterology & hepatology

Kim, W. R.

2020; 16 (2): 95-97

• Cadence from physical activity trackers for monitoring of home-based exercise intensity in advanced liver disease. Liver transplantation : officialpublication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Chen, H. W., Ferrando, A. A., Dunn, M. A., Kim, W. R., Duarte-Rojo, A. n.

2020

• OPTN/SRTR 2018 Annual Data Report: Hepatitis C. American journal of transplantation : official journal of the American Society of Transplantation and theAmerican Society of Transplant Surgeons

Wang, J. H., Gustafson, S. K., Skeans, M. A., Lake, J. R., Kim, W. R., Kasiske, B. L., Israni, A. K., Hart, A.

2020; 20 Suppl s1: 542–68


Kwong, A., Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., Noreen, S. M., Foutz, J., Miller, E., Snyder, J. J., Israni, A. K., Kasiske, B. L.

2020; 20 Suppl s1: 193–299

• Development of Hepatocellular Carcinoma in Patients With Suppressed Viral Replication: Changes in Risk Over Time. Clinical liver disease

Udompap, P. n., Kim, W. R.

2020; 15 (2): 85–90

• Introducing EL-FIT (Exercise and Liver FITness): A Smartphone App to Prehabilitate and Monitor Liver Transplant Candidates. Liver transplantation :official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Duarte-Rojo, A. n., Bloomer, P. M., Rogers, R. J., Hassan, M. A., Dunn, M. A., Tevar, A. D., Vivis, S. L., Bataller, R. n., Hughes, C. B., Ferrando, A. A., Jakicic, J.M., Kim, W. R.

2020

• Cost- Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease. ClinicoEconomics and outcomesresearch : CEOR

Mladsi, D. n., Barnett, C. n., Aggarwal, K. n., Vredenburg, M. n., Dieterich, D. n., Kim, R. n.

2020; 12: 515–26

• Risk Scores for Hepatocellular Carcinoma in Chronic Hepatitis B: A Promise for Precision Medicine. Hepatology (Baltimore, Md.)

Papatheodoridis, G. V., Voulgaris, T. n., Papatheodoridi, M. n., Kim, W. R.


of 32

2020

• Tenofovir Alafenamide Attenuates Effects of Diabetes and Body Mass on Serum Alanine Aminotransferase Activities in Patients with Chronic HepatitisB. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Sripongpun, P. n., Kim, W. R., Mannalithara, A. n., Kwong, A. n., Daugherty, T. n., Goel, A. n., Kwo, P. Y.

2020

• Reply to: "The decreasing predictive power of MELD in an era of changing etiology of liver disease". American journal of transplantation : official journalof the American Society of Transplantation and the American Society of Transplant Surgeons

Kwong, A., Mannalithara, A., Kim, W. R.

2019

• UPDATES FROM THE 2018 OPTN/SRTR ANNUAL DATA REPORT

Kwong, A. J., Kim, W., Lake, J. R., Smith, J., Skeans, M., Snyder, J., Israni, A.

WILEY.2019: 1500A–1501A

• USE OF TRANSIENT ELASTOGRAPHY TO ASSESS ALLOGRAFT QUALITY IN DECEASED LIVER DONORS

Duarte-Rojo, A., Heimbach, J., Barone, G. W., Shaheen, M., Lamps, L. W., Rondell, G. P., Tan, E., Concepcion, W., Borja-Cacho, D., Kim, W.

WILEY.2019: 1501A

• Cost-Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease

Allen, L. F., Aggarwal, K., Vredenburg, M., Barnett, C., Mladsi, D., Kim, R.

AMER SOC HEMATOLOGY.2019

• FIB-8 SCORE: A MODEL INCORPORATING ADDITIONAL COMMON VARIABLES INTO THE FIB-4 SCORE AFFORDS BETTERPREDICTION OF SIGNIFICANT FIBROSIS IN NONALCOHOLIC FATTY LIVER DISEASE

Sripongpun, P., Mannalithara, A., Kim, D., Touros, A., Kim, W.

WILEY.2019: 1037A–1038A

• Real World Evidence Demonstrates a Difference in the Presenting Characteristics of Cirrhotic Patients Who Received Albumin Compared to Those WhoReceived Only Crystalloids

Davis, E., Kim, W., Sindhwani, N. S., Telang, S., Runken, M., Lodaya, K., Raghunathan, K.

LIPPINCOTT WILLIAMS & WILKINS.2019: S1612

• Migration of Patients for Liver Transplantation and Waitlist Outcomes CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

Kwong, A. J., Mannalithara, A., Heimbach, J., Prentice, M. A., Kim, W.

2019; 17 (11): 2347-+

• THE ROLE OF LOCOREGIONAL THERAPY (LRT), POST LRT IMAGING, AND EXPLANT PATHOLOGY AS PREDICTORS OFHEPATOCELLULAR CARCINOMA (HCC) RECURRENCE POST ORTHOTOPIC LIVER TRANSPLANT (OLT)

Prabhakar, V., Dhanasekaran, R., Arjunan, V., Tulu, Z., Ahmed, A., Daugherty, T., Kumari, R., Patel, B., Kim, W., Goel, A., Esquivel, C. O., Concepcion, W.,Melcher, et al

WILEY.2019: 691A–692A

• MORTALITY RISK OF PATIENTS WITH HEPATIC DECOMPENSATION FROM PRIMARY BILIARY CHOLANGITIS IN THE OBETICHOLICACID ERA

Mannalithara, A., Kim, W., Sripongpun, P., Kwong, A. J., Goel, A.

WILEY.2019: 783A

• ALBUMIN IS UNDERUTILIZED IN PATIENTS HOSPITALIZED WITH CIRRHOTIC COMPLICATIONS: REAL WORLD EVIDENCE IN THEUNITED STATES

Raghunathan, K., Sindhwani, N., Davis, E., Kim, W., Telang, S., Runken, M., Lodaya, K.

WILEY.2019: 383A

• LONGER-TERM EXPERIENCE WITH TENOFOVIR ALAFENAMIDE (TAF) IN HBV-INFECTED PATIENTS; CHANGES IN EGFR, FIB4, ALT,AND DNA SUPPRESSION

Reddy, K., Curry, M. P., Bae, H. S., Dieterich, D. T., Ankoma-Sey, V., Pan, C. Q., Hann, H. L., Tong, M. J., Kim, W., Kwo, P., Frazier, L., Cox, K., Milligan, et al

WILEY.2019: 309A

• RISK OF INCIDENT HEPATOCELLULAR CARCINOMA IN HEPATITIS B-INFECTED PATIENTS TREATED WITH TENOFOVIR DISOPROXILFUMARATE VERSUS ENTECAVIR: A US ADMINISTRATIVE CLAIMS ANALYSIS

Kim, W., Telep, L., Lu, M., Ramroth, H., Flaherty, J. F., Gaggar, A., Chokkalingam, A., Gordon, S. C.


of 32

WILEY.2019: 302A–303A

• DIFFERENTIAL TENOFOVIR ALAFENAMIDE (TAF) ADOPTION IN HBV-INFECTED POPULATIONS; ASSESSMENT OF CARE IN USCLINICAL PRACTICE

Curry, M. P., Bae, H. S., Dieterich, D. T., Ankoma-Sey, V., Reddy, K., Pan, C. Q., Hann, H. L., Tong, M. J., Kim, W., Kwo, P., Frazier, L., Cox, K., Milligan, et al

WILEY.2019: 308A–309A

• BEYOND THE BIRTH COHORT: STRATEGIES FOR HEPATITIS C SCREENING FOR AMERICANS BORN AFTER 1965

Sripongpun, P., Udompap, P., Mannalithara, A., Kwong, A. J., Kim, W.

WILEY.2019: 348A–349A

• Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis. Journal of gastroenterology

Kim, D., Kim, W., Joo, S. K., Han, J., Kim, J. H., Harrison, S. A., Younossi, Z. M., Ahmed, A.

2019

• MELD-GRAIL-Na: Glomerular filtration rate and mortality on Liver-Transplant Waiting List. Hepatology (Baltimore, Md.)

Asrani, S. K., Jennings, L. W., Kim, W. R., Kamath, P., Levitsky, J., Nadim, M. K., Testa, G., Leise, M., Trotter, J. F., Klintmalm, G.

2019

• Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014 LIVER INTERNATIONAL

Kim, D., Cholankeril, G., Li, A. A., Kim, W., Tighe, S. P., Hameed, B., Kwo, P. Y., Harrison, S. A., Younossi, Z. M., Ahmed, A.

2019; 39 (9): 1661–71

• The interaction of nonalcoholic fatty liver disease and smoking on mortality among adults in the United States LIVER INTERNATIONAL

Wijarnpreecha, K., Scribani, M., Kim, D., Kim, W.

2019; 39 (7): 1202–6

• CLINICAL PRACTICE EXPERIENCE WITH TENOFOVIR ALAFENAMIDE (TAF) FOR TREATMENT OF HEPATITIS B IN THE US

Curry, M., Bae, H., Dieterich, D., Ankoma-Sey, Reddy, R., Pan, C., Hann, H. W., Tong, M., Kim, W. R., Kwo, P., Frazier, L., Milligan, S., Radtchenko, J., et al

ELSEVIER SCIENCE INC.2019: S196

• Association between body size-metabolic phenotype and non-alcoholic steatohepatitis and significant fibrosis

Kim, W., Kim, D., Harrison, S., Younossi, Z., Ahmed, A.

ELSEVIER SCIENCE BV.2019: E300–E301

• Primary biliary cholangitis-Autoimmune hepatitis overlap syndrome: Characteristics and response to obeticholic acid in TARGET-PBC, a diverse, largeUnited States real-world cohort

Mayo, M. J., Bowlus, C., Carey, E., Little, E., Deane, K., Zink, R., Sandefur, R., Kim, W., Levy, C.

ELSEVIER SCIENCE BV.2019: E403

• Latent trajectory analysis of serum creatinine in patients with end stage liver disease: Predictors of pre- and post-transplant outcomes

Kim, W., Asrani, S., Biggins, S., Sripongpun, P., Mannalithara, A.

ELSEVIER SCIENCE BV.2019: E562–E563

• Effectiveness and safety with tenofovir alafenamide (TAF) for hepatitis B in US clinical practice

Curry, M., Bae, H., Dieterich, D., Ankoma-Sey, V., Reddy, R., Pan, C., Hann, H., Tong, M., Kim, W., Kwo, P., Frazier, L., Milligan, S., Spitz, et al


• Change in lipids: Characteristics and response to obeticholic acid in TARGET-PBC, a diverse, large United States real-world cohort

Levy, C., Mayo, M. J., Carey, E., Little, E., Kim, W., Deane, K., Zink, R., Sandefur, R., Bowlus, C.


• Liver Circle-Based Allocation: LSAM Modeling Results.

Schladt, D., Weaver, T., Pyke, J., Herreid, A., Thompson, B., Kasiske, B., Snyder, J., Kim, W., Lake, J., Israni, A., Heimbach, J.

WILEY.2019: 1001

• Liver Transplant Centers Select Different Characteristics for Recipients and Deceased Donors: Implications for Patients When Choosing a Center.

Schaffhausen, C. R., Bruin, M. J., Chu, S., Schladt, D., Chinnakotla, S., Lake, J. R., Kim, W., Biggins, S. W., Snyder, J. J., Kasiske, B. L., Israni, A. K.

WILEY.2019: 715

• Liver Waitlist Dropout and Transplant Rates for Metropolitan vs. Non-Metropolitan Candidates.


of 32

Schladt, D., Weaver, T., Pyke, J., Herreid, A., Thompson, B., Kasiske, B., Snyder, J., Kim, W., Lake, J., Israni, A.

WILEY.2019: 1040

• A Randomized Pilot Trial of Home-Based Physical Activity Plus Dietary Intervention to Improve Physical Function in Patients with Advanced LiverDisease.

Chen, H., Fernando, A. A., White, M. G., Pauly, M., Bartter, T., Dunn, M. A., Kim, W. R., Duarte-Rojo, A.

WILEY.2019: 717–18

• Continuous Distribution: LSAM Simulation Study.

Weaver, T., Salkowski, N., Snyder, J., Schladt, D., Pyke, J., Herreid, A., Thompson, B., Kim, W., Lake, J., Israni, A.

WILEY.2019: 377

• Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the UnitedStates HEPATOLOGY

Kim, D., Li, A. A., Perumpail, B. J., Gadiparthi, C., Kim, W., Cholankeril, G., Glenn, J. S., Harrison, S. A., Younossi, Z. M., Ahmed, A.

2019; 69 (3): 1064–74

• A Model for Glomerular Filtration Rate Assessment in Liver Disease (GRAIL) in the Presence of Renal Dysfunction HEPATOLOGY

Asrani, S. K., Jennings, L. W., Trotter, J. F., Levitsky, J., Nadim, M. K., Kim, W. R., Gonzalez, S. A., Fischbach, B., Bahirwani, R., Emmett, M., Klintmalm, G.

2019; 69 (3): 1219–30

• Impact of Sofosbuvir-Based Therapy on Liver Transplant Candidates with Hepatitis C Virus Infection. Pharmacotherapy

Dellay, B., Sexter, A., Wang, J. H., Hess, G. P., Kim, W. R., Israni, A. K.

2019

• OPTN/SRTR 2017 Annual Data Report: Liver AMERICAN JOURNAL OF TRANSPLANTATION

Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., Noreen, S. M., Robinson, A. M., Miller, E., Snyder, J. J., Israni, A. K., Kasiske, B. L.

2019; 19

• A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Resultsof the ENUMERATE Study DIGESTIVE DISEASES AND SCIENCES

Lee, H. M., Ahn, J., Kim, W., Lim, J. K., Nguyen, M., Pan, C. Q., Kim, D., Mannalithara, A., Te, H., Huy Trinh, Chu, D., Tram Tran, Woog, J., Lok, et al

2019; 64 (2): 358–66


Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., Noreen, S. M., Robinson, A. M., Miller, E., Snyder, J. J., Israni, A. K., Kasiske, B. L.

2019; 19 Suppl 2: 184–283

• The interaction of nonalcoholic fatty liver disease and smoking on mortality among adults in the United States. Liver international : official journal of theInternational Association for the Study of the Liver

Wijarnpreecha, K., Scribani, M., Kim, D., Kim, W. R.

2019

• Diagnosis and Management of Primary Biliary Cholangitis AMERICAN JOURNAL OF GASTROENTEROLOGY

Younossi, Z. M., Bernstein, D., Shiffman, M. L., Kwo, P., Kim, W., Kowdley, K. V., Jacobson, I. M.

2019; 114 (1): 48–63

• Migration of Patients for Liver Transplantation and Waitlist Outcomes. Clinical gastroenterology and hepatology : the official clinical practice journal of theAmerican Gastroenterological Association

Kwong, A. J., Mannalithara, A. n., Heimbach, J. n., Prentice, M. A., Kim, W. R.

2019

• Potential Benefits of Switching Liver Transplant Recipients to Tenofovir Alafenamide Prophylaxis. Clinical gastroenterology and hepatology : the officialclinical practice journal of the American Gastroenterological Association

Sripongpun, P. n., Mannalithara, A. n., Kwo, P. Y., Kim, W. R.

2019

• Defining a willingness-to-transplant threshold in an era of organ scarcity: Simultaneous liver-kidney transplant as a case example. Transplantation

Cheng, X. S., Goldhaber-Fiebert, J. n., Tan, J. C., Chertow, G. M., Kim, W. R., Wall, A. E.

2019


of 32

• Longitudinal trends in renal function in chronic hepatitis B patients receiving oral antiviral treatment ALIMENTARY PHARMACOLOGY &THERAPEUTICS

Udompap, P., Kim, D., Ahmed, A., Kim, W.

2018; 48 (11-12): 1282–89

• Hemoglobin A1c Has Suboptimal Performance to Diagnose and Monitor Diabetes Mellitus in Patients with Cirrhosis DIGESTIVE DISEASES ANDSCIENCES

Addepally, N. S., George, N., Martinez-Macias, R., Garcia-Saenz-de-Sicilia, M., Kim, W., Duarte-Rojo, A.

2018; 63 (12): 3498–3508

• Diagnosis and Management of Primary Biliary Cholangitis. The American journal of gastroenterology

Younossi, Z. M., Bernstein, D., Shiffman, M. L., Kwo, P., Kim, W. R., Kowdley, K. V., Jacobson, I. M.

2018

• Longitudinal trends in renal function in chronic hepatitis B patients receiving oral antiviral treatment. Alimentary pharmacology & therapeutics

Udompap, P., Kim, D., Ahmed, A., Kim, W. R.

2018

• A model for Glomerular filtration Rate Assessment In Liver disease (GRAIL) in the presence of renal dysfunction. Hepatology (Baltimore, Md.)

Asrani, S. K., Jennings, L. W., Trotter, J. F., Levitsky, J., Nadim, M. K., Kim, W. R., Gonzalez, S. A., Fischbach, B., Bahirwani, R., Emmett, M., Klintmalm, G.

2018

• De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era HEPATOLOGY

Kwong, A. J., Kim, W., Flemming, J. A.

2018; 68 (4): 1288–97

• Early Adoption of Tenofovir Alafenamide (TAF) for Hepatitis B in US Clinical Practice; Real-World Evidence from the Trio Network

Curry, M. P., Bae, H., Dieterich, D. T., Ankoma-Sey, V., Reddy, K., Pan, C. Q., Hann, H. L., Tong, M. J., Kim, W., Kwo, P., Reau, N., Frazier, L., Milligan, et al

WILEY.2018: 252A

• Patient Reported Indicators of Health and Symptoms in US Patients with Primary Biliary Cholangitis (PBC)

Carey, E. J., Levy, C., Mayo, M. J., Bowlus, C. L., Deane, K., Sandefur, R. A., Laliberte, P., Zink, R. C., Kim, W.

WILEY.2018: 1107A–1108A

• Treatment of Hepatitis B in the Us; Real-World Evidence from the Trio Network

Bae, H., Curry, M. P., Dieterich, D. T., Ankoma-Sey, V., Reddy, K., Pan, C. Q., Hann, H. L., Tong, M. J., Kim, W., Kwo, P., Reau, N., Frazier, L., Milligan, et al

WILEY.2018: 264A–265A

• Providing Liver Transplant Candidates with Patient-Friendly Reports about Transplant Programs

Schaffhausen, C., Bruin, M., Chu, S., Matas, A., Lake, J. R., Kim, W., Biggins, S. W., Snyder, J., Kasiske, B., Israni, A.

WILEY.2018: 315A

• Prediction of Mortality Risk in Decompensated Cirrhosis Due to Primary Biliary Cholangitis

Kwong, A. J., Goel, A., Mannalithara, A., Iloeje, U., Feng, C., Kim, W.

WILEY.2018: 1098A–1099A

• Refit and Validation of Peld Score

Schladt, D., Wey, A., Herreid, A., Pyke, J., Weaver, T., Snyder, J., Israni, J., Kim, W., Lake, J. R.

WILEY.2018: 762A–763A

• Risk Prediction Models for Graft Failure after Liver Transplantation: A Machine-Learning Approach

Kwong, A. J., O'Connell, C., Kanzawa, M., Hufker, K., Lindsay, N., Kim, W.

WILEY.2018: 668A–669A

• Reduced Access to Liver Transplantation in Women: Role of Height, MELD Exception Scores, and Renal Function Underestimation TRANSPLANTATION

Allen, A. M., Heimbach, J. K., Larson, J. J., Mara, K. C., Kim, W., Kamath, P. S., Therneau, T. M.

2018; 102 (10): 1710–16

• Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis HEPATOLOGY

Yang, J., Mannalithara, A., Piscitello, A. J., Kisiel, J. B., Gores, G. J., Roberts, L. R., Kim, W.


of 32

2018; 68 (1): 78–88

• Emerging Therapies Toward a Functional Cure for Hepatitis B Virus Infection. Gastroenterology & hepatology

Kim, W. R.

2018; 14 (7): 439–42

• Liver Stiffness Measurement, but Not Controlled Attenuation Parameter, is Increased in Deceased Liver Donors at the Time of Transplant Procurement.

Duarte-Rojo, A., Barone, G., Borja-Cacho, D., Concepcion, W., Shaheen, M., Heimbach, J., Kim, W.

WILEY.2018: 406

• Evaluating Displays of Program Waitlist Mortality on Public Search Results.

Schaffhausen, C., Bruin, M., Chu, S., Matas, A., Lake, J., Kim, W., Biggins, S., Snyder, J., Kasiske, B., Israni, A.

WILEY.2018: 741–42

• Race, Income, and Insurance Status Predict Migration for Liver Transplantation in the United States.

Kwong, A., Mannalithara, A., Kim, W.

WILEY.2018: 308–9

• Providing Transplant Candidates with Guidance about Differences in Acceptance Criteria across Programs.


WILEY.2018: 745

• Calibration of Updated LSAM.

Pyke, J., Weaver, T., Schladt, D., Salkowski, N., Wey, A., Lake, J., Kim, W., Gentry, S., Israni, A.

WILEY.2018: 577–78

• Large Decrease in Liver Waiting List Dropout Rate for MELD > 14.

Schladt, D., Pyke, J., Israni, A., Kim, W., Lake, J., Snyder, J.

WILEY.2018: 567–68

• Accepting a DCD Liver May Improve Patient Survival Compared to Waiting for a Non-DCD Liver.

Wey, A., Salkowski, N., Lake, J., Kim, W., Kasiske, B., Israni, A., Snyder, J.

WILEY.2018: 382

• Is Percent Exception at Transplant a Driver of MELD Inflation?

Schladt, D., Snyder, J., Israni, A., Kim, W., Lake, J.

WILEY.2018: 571

• Providing Transplant Candidates with Patient-Specific Public Reports about Programs That Transplant Patients Like Them.


WILEY.2018: 739

• Performance of Donor Risk Index in the MELD era

Kwong, A., Kim, W. R.

LIPPINCOTT WILLIAMS & WILKINS.2018: 19

• Comparing Simultaneous Liver-Kidney Transplant Strategies: A Modified Cost-Effectiveness Analysis TRANSPLANTATION

Cheng, X. S., Kim, W., Tan, J. C., Chertow, G. M., Goldhaber-Fiebert, J.

2018; 102 (5): E219–E228

• A Real-World Observational Cohort of Patients With Primary Biliary Cholangitis: TARGET-Primary Biliary Cholangitis Study Design andRationale HEPATOLOGY COMMUNICATIONS

Levy, C., Bowlus, C. L., Carey, E., Crawford, J. M., Deane, K., Mayo, M. J., Kim, W., Fried, M. W.

2018; 2 (5): 484–91

• MELD dynamics predicts waitlist outcomes in patients awaiting liver transplantation

Kim, B. H., Mannalithara, A., Kwong, A., Kim, W. R.

ELSEVIER SCIENCE BV.2018: S381–S382

• Distinct MELD trajectories in liver transplant candidates with hepatitis C and non-alcoholic steatohepatitis



of 32


• Avatrombopag decreases need for platelet transfusion in patients chronic liver disease and thrombocytopenia undergoing medical procedures with low tohigh associated bleeding risks

Reau, N. S., Sammy, S., Allen, L. F., Aggarwal, K., Vredenburg, M., Kim, W. R.

ELSEVIER SCIENCE BV.2018: S751

• Survival benefits of direct-acting antiviral therapy in patients with decompensated hepatitis C cirrhosis

Kim, W. R., Osinusi, A., Mannalithara, A., Schall, R. A., Brainard, D.


• Comparing Simultaneous Liver-Kidney Transplant Strategies: A Modified Cost-Effectiveness Analysis. Transplantation

Cheng, X. S., Kim, W. R., Tan, J. C., Chertow, G. M., Goldhaber-Fiebert, J.

2018

• Nonalcoholic Fatty Liver Disease and Metabolic Syndrome Clinics in Liver Disease

Kim, D., Touros, A., Kim, W.

2018; 22 (1): 133-140

• A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Resultsof the ENUMERATE Study. Digestive diseases and sciences

Lee, H. M., Ahn, J. n., Kim, W. R., Lim, J. K., Nguyen, M. n., Pan, C. Q., Kim, D. n., Mannalithara, A. n., Te, H. n., Trinh, H. n., Chu, D. n., Tran, T. n., Woog, etal

2018

• Nonalcoholic Fatty Liver Disease and Metabolic Syndrome. Clinics in liver disease

Kim, D. n., Touros, A. n., Kim, W. R.

2018; 22 (1): 133–40

• Natural History of Primary Biliary Cholangitis in the Ursodeoxycholic Acid Era: Role of Scoring Systems. Clinics in liver disease

Goel, A. n., Kim, W. R.

2018; 22 (3): 563–78

• Natural History of Primary Biliary Cholangitis in the Ursodeoxycholic Acid Era: Role of Scoring Systems Clinics in Liver Disease

Goel, A., Kim, W. R.

2018; 22 (3): 563-578

• Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waitinglist LIVER TRANSPLANTATION

Duarte-Rojo, A., Ruiz-Margain, A., Montano-Loza, A. J., Macias-Rodriguez, R. U., Ferrando, A., Kim, W.

2018; 24 (1): 122–39


Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., Harper, A. M., Wainright, J. L., Snyder, J. J., Israni, A. K., Kasiske, B. L.

2018; 18: 172–253

• De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era. Hepatology (Baltimore, Md.)

Kwong, A. J., Kim, W. R., Flemming, J. A.

2018

• Liver Simulated Allocation Modeling: Were the Predictions Accurate for Share 35? Transplantation

Goel, A. n., Kim, W. R., Pyke, J. n., Schladt, D. P., Kasiske, B. L., Snyder, J. J., Lake, J. R., Israni, A. K.

2018

• Survival Benefit of Direct Acting Antiviral Therapy in Patients with Decompensated Cirrhosis

Kim, W., Mannalithara, A., Lee, H., Osinusi, A. O., Schall, R., Brainard, D. M.

WILEY.2017: 1270A–1271A

• Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis. Hepatology (Baltimore, Md.)

Yang, J. D., Mannalithara, A., Piscitello, A. J., Kisiel, J. B., Gores, G. J., Roberts, L. R., Kim, W. R.

2017


of 32

• Donor Age and Allograft Survival in Recipients with Hepatitis C Virus in the Direct-Acting Antiviral Era

Kwong, A. J., Kim, N. G., Stoltz, D., Mannalithara, A., Kim, W.

WILEY.2017: 886A–887A

• Is it necessary to screen for varices in cirrhotic patients who are receiving entecavir or tenofovir for chronic hepatitis B?

Wong, V. W., Yip, T., Leung, J. C., Wong, J. C., Tse, Y., Kim, W., Chan, H., Wong, G. L.

WILEY.2017: 249A

• HCC 6-Month Delay: Comparison of LSAM to Observed

Schladt, D. P., Zeglin, J., Snyder, J., Israni, A., Kim, W., Lake, J. R.

WILEY.2017: 885A–886A

• Characteristics and Costs of NASH Advanced Fibrosis and Cirrhosis in Patients with and without Diabetes Mellitus (DM): Results of a US Real-WorldCohort Study

Sanyal, A. J., Bengtson, L., Shreay, S., Kim, W.

WILEY.2017: 1168A–1169A

• Sofosbuvir-based therapy is associated with higher incidence of de-registration for clinical improvement in hepatitis C patients awaiting livertransplantation: Analysis of SRTR-Symphony Database

Kim, W., Dellay, B., Wang, J. H., Peng, Y., Sexter, A., Israni, A.

WILEY.2017: 872A–873A

• Reduced Incidence of Kidney Waitlisting After Liver Transplantation in the Post-Share 35 Era

Kwong, A. J., Mannalithara, A., Asrani, S. K., Biggins, S. W., Heimbach, J., Brandman, D., Abt, P. L., Kim, W.

WILEY.2017: 15A

• Continued Increase in Incidence of De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants with Hepatitis C Virus Infection

Kwong, A. J., Kim, W., Flemming, J. A.

WILEY.2017: 71A

• A Prognostic Model for Liver Transplant Candidates with Hepatitis C - A Decision Aid for Antiviral Therapy

Lee, H., Mannalithara, A., Asrani, S. K., Biggins, S. W., Heimbach, J., Brandman, D., Abt, P. L., Kwo, P. Y., Kim, W.

WILEY.2017: 548A–549A

• Trajectory of Serum Creatinine in Liver Transplant Candidates Identifies Patients at High Risk of Mortality

Kwong, A. J., Mannalithara, A., Biggins, S. W., Asrani, S. K., Brandman, D., Abt, P. L., Heimbach, J., Kim, W.

WILEY.2017: 947A

• Race and Socioeconomic Status Predict Migration for Liver Transplantation in the United States

Kwong, A. J., Mannalithara, A., Heimbach, J., Kim, W.

WILEY.2017: 306A–307A

• Rapidly Rising Burden of Portopulmonary Hypertension in the United States

Rahim, U., Mannalithara, A., Kim, D., Zamanian, R., Kim, W.

WILEY.2017: 253A–254A

• Characteristics of US-Born Versus Foreign-Born Americans of African Descent With Chronic Hepatitis B AMERICAN JOURNAL OF EPIDEMIOLOGY

Hassan, M. A., Kim, W., Li, R., Smith, C. I., Fried, M. W., Sterling, R. K., Ghany, M. G., Wahed, A. S., Ganova-Raeva, L. M., Roberts, L. R., Lok, A. F., HepatitisB Res Network

2017; 186 (3): 356–66

• Improved Post-Transplant Mortality After Share 35 for Liver Transplantation. Hepatology (Baltimore, Md.)

Kwong, A. J., Goel, A., Mannalithara, A., Kim, W. R.

2017

• Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates. Liver transplantation

Kim, S. G., Larson, J. J., Lee, J. S., Therneau, T. M., Kim, W. R.

2017; 23 (6): 733-740

• Utility in Treating Kidney Failure in End-Stage Liver Disease With Simultaneous Liver-Kidney Transplantation TRANSPLANTATION


of 32

Cheng, X. S., Stedman, M. R., Chertow, G. M., Kim, W. R., Tan, J. C.

2017; 101 (5): 1111-1119

• PERSPECTIVES IN CLINICAL GASTROENTEROLOGY AND HEPATOLOGY CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

Kim, D., Kim, W. R.

2017; 15 (4): 474-485

• A Markov Model for Transplant & Renal Outcomes After Liver & Simultaneous Liver-Kidney Transplants.

Cheng, X., Kim, W., Tan, J., Goldhaber-Fiebert, J.

WILEY.2017: 806

• Reduction in Liver Transplant Wait-Listing in the Era of Direct-Acting Antiviral Therapy HEPATOLOGY

Flemming, J. A., Kim, W. R., Brosgart, C. L., Terrault, N. A.

2017; 65 (3): 804-812

• Impact of direct-acting antiviral agents-induced SVR on the long-term burden of hepatocellular carcinoma in chronic hepatitis C cirrhosis.

Udompap, P., Mannalithara, A., Kim, D., Kim, W.

AMER SOC CLINICAL ONCOLOGY.2017

• Long-term Patient and Graft Survival of Kidney Transplant Recipients with Hepatitis C Virus Infection in the United States. Transplantation

Heo, N. Y., Mannalithara, A. n., Kim, D. n., Udompap, P. n., Tan, J. C., Kim, W. R.

2017

• Steatotic donor livers are increasingly used with minimal effect on graft survival



• Change in the trajectory of MELD scores in liver transplant candidates with hepatitis C in the direct acting antiviral era

Kwong, A., Mannalithara, A., Kim, D., Kim, W. R.


• An alternative screening strategy for hepatitis C virus infection among americans not belonging in the baby boomer birth cohort

Udompap, P., Mannalithara, A., Kwong, A. J., Kim, D., Kim, W. R.


• Model for end stage liver disease score dynamics in patients awaiting liver transplantation and waitlist outcomes

Mannalithara, A., Chan, J. L., Hagerty, D., Kim, W. R.


• Model for end stage liver disease score dynamics in NASH patients awaiting liver transplantation and waitlist outcomes

Mannalithara, A., Chan, J. L., Hagerty, D., Kim, W. R.


• Determinants of the future burden of hepatocellular carcinoma after eradication of hepatitis C virus among cirrhotic patients

Udompap, P., Mannalithara, A., Kwong, A. J., Kim, D., Dhanasekaran, R., Kim, W. R.


• Decreasing Mortality and Disease Severity in Hepatitis C Patients Awaiting Liver Transplantation in the United States. Liver transplantation : officialpublication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Kwong, A. n., Kim, W. R., Mannalithara, A. n., Heo, N. Y., Udompap, P. n., Kim, D. n.

2017

• Short Sleep Duration Is Associated With Abnormal Serum Aminotransferase Activities and Nonalcoholic Fatty Liver Disease. Clinical gastroenterologyand hepatology : the official clinical practice journal of the American Gastroenterological Association

Kim, D. n., Kim, H. J., Kushida, C. A., Heo, N. Y., Ahmed, A. n., Kim, W. R.

2017


Kim, W. R., Lake, J. R., Smith, J. M., Skeans, M. A., Schladt, D. P., Edwards, E. B., Harper, A. M., Wainright, J. L., Snyder, J. J., Israni, A. K., Kasiske, B. L.

2017; 17: 174–251


of 32

• Decreasing Mortality and Disease Severity in Hepatitis C Patients Awaiting Liver Transplantation in the United States. Liver Transplantation

Kwong, A., Kim, W., Mannalithara , A., Heo, N., Udompap, P., Kim, D.

2017

• Management of Renal Failure in End-Stage Liver Disease: A Critical Appraisal LIVER TRANSPLANTATION

Cheng, X. S., Tan, J. C., Kim, W. R.

2016; 22 (12): 1710-1719

• Reduction in Liver Transplant Wait-Listing in the Era of Direct Acting Anti-Viral Therapy

Flemming, J. A., Kim, W., Brosgart, C. L., Terrault, N.

WILEY.2016: 1133A

• Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis AMERICAN JOURNAL OFGASTROENTEROLOGY

Yang, J. D., Mohamed, H. A., Cvinar, J. L., Gores, G. J., Roberts, L. R., Kim, W. R.

2016; 111 (11): 1572-1580

• Time trends in the health care burden and mortality of acute on chronic liver failure in the United States. Hepatology

Allen, A. M., Kim, W. R., Moriarty, J. P., Shah, N. D., Larson, J. J., Kamath, P. S.

2016

• Predicting Outcomes on the Liver Transplant Waiting List in the United States: Accounting for Large Regional Variation in Organ Availability andPriority Allocation Points. Transplantation

Hart, A., Schladt, D. P., Zeglin, J., Pyke, J., Kim, W. R., Lake, J. R., Roberts, J. P., Hirose, R., Mulligan, D. C., Kasiske, B. L., Snyder, J. J., Israni, A. K.

2016; 100 (10): 2153-2159

• The Use of HCV Positive Donors in HCV Negative Liver Transplant Recipients

Cholankeril, G., Perumpail, R. B., Hu, M., Aggarwal, A., Liu, A., Kwong, A. J., Dhanasekaran, R., Bonham, C. A., Gonzalez, S. A., Kim, W., Esquivel, C. O.,Ahmed, A.

WILEY.2016: 807A

• Impact of Antiviral Nucleotide Analogues on Age-Dependent Decline in Renal Function

Udompap, P., Mannalithara, A., Kim, D., Kim, W.

WILEY.2016: 925A–926A

• Is cirrhosis reversible in patients with hepatitis C and decompensated liver disease? Explant histology in patients with sustained virologic response

Kwong, A., Kim, W., Higgins, J.

WILEY.2016: 395A

• Nonalcoholic Fatty Liver Disease in the Non-obese: Insights from the PIVENS and FLINT Trials

Kim, D., Mannalithara, A., Udompap, P., Kim, W.

WILEY.2016: 537A

• Decreasing Mortality in Hepatitis C Patients Awaiting Liver Transplantation in the Direct Acting Antiviral Era

Kim, D., Kwong, A., Mannalithara, A., Heo, N., Udompap, P., Kim, W.

WILEY.2016: 29A

• Predictors of Waitlist Outcomes in Candidates with Primary Biliary Cholangitis awaiting Liver Transplantation

Cholankeril, G., Perumpail, R. B., Wong, R. J., Yoo, E. R., Hu, M., Jayasekera, C. R., Saab, S., Kim, W., Harrison, S. A., Ahmed, A.

WILEY.2016: 109A

• Evolving Demographic Trends in Liver Transplant Waitlist for Primary Biliary Cholangitis

Cholankeril, G., Perumpail, R. B., Yoo, E. R., Hu, M., Kim, W., Ahmed, A.

WILEY.2016: 203A–204A

• The Effect of Gastric Acid Suppression on Ledipasivir-Sofosbuvir Effectiveness in Chronic Hepatitis C Infection

Swanner, A., Kumari, R., Garcia, G., Daugherty, T., Nguyen, M. H., Ahmed, A., Kim, W., Lutchman, G. A.

WILEY.2016: 947A

• Protecting the Kidney in Liver Transplant Candidates: Practice-Based Recommendations From the American Society of Transplantation Liver andIntestine Community of Practice AMERICAN JOURNAL OF TRANSPLANTATION


of 32

O'Leary, J. G., Levitsky, J., Wong, F., Nadim, M. K., Charlton, M., Kim, W. R.

2016; 16 (9): 2516-2531

• Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATEStudy. American journal of gastroenterology

Ahn, J., Lim, J. K., Lee, H. M., Lok, A. S., Nguyen, M., Pan, C. Q., Mannalithara, A., Te, H., Reddy, K. R., Trinh, H., Chu, D., Tran, T., Lau, et al

2016; 111 (9): 1297-1304

• Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATEStudy AMERICAN JOURNAL OF GASTROENTEROLOGY

Ahn, J., Lim, J. K., Lee, H. M., Lok, A. S., Mindie Nguyen, M., Pan, C. Q., Mannalithara, A., Te, H., Reddy, K. R., Huy Trinh, H., Chu, D., Tram Tran, T., Lau, etal

2016; 111 (9): 1297-1304

• Nonobese Fatty Liver Disease. Clinical gastroenterology and hepatology

Kim, D., Kim, W. R.

2016

• Potential Efficacy of Pegylated Interferon-alpha and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B GUTAND LIVER

Wi, C., Kim, W. R., Gross, J. B., Stadheim, L. M., Poterucha, J. J.

2016; 10 (4): 611-616

• Impact of Proximity MELD/PELD Points on Liver Redistricting Scenarios.

Gentry, S., Pyke, J., Schladt, D., Zeglin, J., Kim, W., Lake, J., Hirose, R., Mulligan, D., Israni, A.

WILEY-BLACKWELL.2016: 358–59

• Utility in Treating Renal Failure in End-Stage Liver Disease with Simultaneous Liver-Kidney Transplantation.

Cheng, X., Stedman, M., Kim, W., Tan, J.

WILEY-BLACKWELL.2016: 232–33

• Increasing prevalence of cirrhosis among U.S. adults aware or unaware of their chronic hepatitis C virus infection. Journal of hepatology

Udompap, P., Mannalithara, A., Heo, N., Kim, D., Kim, W. R.

2016; 64 (5): 1027-1032

• Epidemiology and Healthcare Burden of Acute-on-Chronic Liver Failure SEMINARS IN LIVER DISEASE

Allen, A. M., Kim, W. R.

2016; 36 (2): 123-126

• Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients JOURNAL OF HEPATOLOGY

Kim, W. R., Berge, T., Asselah, T., Flisiak, R., Fung, S., Gordon, S. C., Janssens, H. L., Lampertico, P., Lau, D., Bornstein, J. D., Schall, R. E., Dinh, P., Yee, et al

2016; 64 (4): 773-780

• Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. Journal of hepatology

Kim, W. R., Berg, T., Asselah, T., Flisiak, R., Fung, S., Gordon, S. C., Janssen, H. l., Lampertico, P., Lau, D., Bornstein, J. D., Schall, R. E., Dinh, P., Yee, et al

2016; 64 (4): 773-780

• Hepatitis B Virus-Specific and Global T-Cell Dysfunction in Chronic Hepatitis B GASTROENTEROLOGY

Park, J., Wong, D. K., Wahed, A. S., Lee, W. M., Feld, J. J., Terrault, N., Khalili, M., Sterling, R. K., Kowdley, K. V., Bzowej, N., Lau, D. T., Kim, W. R., Smith,et al

2016; 150 (3): 684-?

• The Epidemiology of Liver Diseases Unique to Pregnancy in a US Community: A Population-Based Study CLINICAL GASTROENTEROLOGY ANDHEPATOLOGY

Allen, A. M., Kim, W. R., Larson, J. J., Rosedahl, J. K., Yawn, B. P., McKeon, K., Hay, J. E.

2016; 14 (2): 287-?

• Entecavir safety and effectiveness in a national cohort of treatment-naive chronic hepatitis B patients in the US - the ENUMERATE study ALIMENTARYPHARMACOLOGY & THERAPEUTICS

Ahn, J., Lee, H. M., Lim, J. K., Pan, C. Q., Nguyen, M. H., Kim, W. R., Mannalithara, A., Trinh, H., Chu, D., Tran, T., Min, A., Do, S., Te, et al

2016; 43 (1): 134-144


of 32

• IMPACT OF CONTINUOUS POSITIVE AIRWAY PRESSURE TREATMENT ON NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTSWITH OBSTRUCTIVE SLEEP APNEA

Kim, D., Mannalithara, A., Udompap, P., Kushida, C., Kim, W.


• LIVER AMERICAN JOURNAL OF TRANSPLANTATION


2016; 16: 69–98

• A POTENTIAL ROLE OF SEX HORMONES IN THE PROGRESSION OF END STAGE LIVER DISEASE

Udompap, P., Mannalithara, A., Kim, D., Kim, W. R.


• Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis. The American journal of gastroenterology

Yang, J. D., Mohamed, H. A., Cvinar, J. L., Gores, G. J., Roberts, L. R., Kim, W. R.

2016; 111 (11): 1573–80

• Current and Future Burden of Chronic Nonmalignant Liver Disease. Clinical gastroenterology and hepatology

Udompap, P., Kim, D., Kim, W. R.

2015; 13 (12): 2031-2041

• Diabetes and prediabetes in patients with hepatitis B residing in North America HEPATOLOGY

Khalili, M., Lombardero, M., Chung, R. T., Terrault, N. A., Ghany, M. G., Kim, W. R., Lau, D., Lisker-Melman, M., Sanyal, A., Lok, A. S.

2015; 62 (5): 1364-1374

• Korean Version of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma (K-MESIAH) PLOS ONE

Nam, B., Park, J., Jeong, S., Lee, S. S., Yu, A., Kim, B. H., Kim, W. R.

2015; 10 (10)

• Impact of Long-Term Tenofovir Disoproxil Fumarate on Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B CANCER

Kim, W. R., Loomba, R., Berg, T., Schall, R. E., Yee, L. J., Dinh, P. V., Flaherty, J. F., Martins, E. B., Therneau, T. M., Jacobson, I., Fung, S., Gurel, S., Buti, et al

2015; 121 (20): 3631-3638

• Reduced Survival in Elderly Liver Transplant Recipients: How Old is Too Old?

Heo, N., Mannalithara, A., Udompap, P., Kim, D., Concepcion, W., Esquivel, C. O., Kim, W.

WILEY.2015: 807A

• IFN and/or RBV-Free Therapy (Rx) with Simeprevir plus Sofosbuvir (SMV plus SOF) was Well-Tolerated and Effective for Chronic Hepatitis CGenotype 1 (CHC-1) Including Post-Liver Transplant (LT) and Decompensated Non-Liver Transplant (Non-LT) Patients: A Single-Center Experience

Lutchman, G. A., Nguyen, N. H., Chang, C. Y., Ahmed, A., Daugherty, T., Garcia, G., Kumari, R., Kim, W., Gupta, S., Doshi, D., Nguyen, M. H.

WILEY-BLACKWELL.2015: 797A–798A

• Similar Tolerability and Effectiveness with SMV plus SOF Therapy in Asians and Non-Asians with Chronic Hepatitis C Genotype 1 (CHC-1) but Anemiaand Fatigue were Common with SOF plus RBV in Both Groups

Chang, C. Y., Nguyen, N. H., Zhao, C., Lutchman, G. A., Ahmed, A., Daugherty, T., Garcia, G., Kumari, R., Kim, W., Trinh, H. N., Vu, V. D., Ku, W., Nguyen, etal

WILEY-BLACKWELL.2015: 794A

• Reduced Survival in Elderly Liver Transplant Recipients: How Old is Too Old?

Heo, N., Mannalithara, A., Udompap, P., Kim, D., Concepcion, W., Esquivel, C. O., Kim, W.

WILEY.2015: 807A

• Healthcare Utilization Related to Hepatitis C: It Is More Than the Virus

Kim, W., Reau, N., Shiffman, M., Cournand, H., Hassanein, T.

NATURE PUBLISHING GROUP.2015: S886–S887

• Could Share 35 disadvantage women?

Allen, A. M., Heimbach, J., Larson, J. J., Kim, W., Kamath, P. S., Therneau, T. M.



of 32

• Clinical Epidemiology of Primary Biliary Cirrhosis based on a Large US Laboratory Database: Incidence and Trends in Serum Alkaline Phosphatase

Kim, W., Mayne, T. J., Marmon, T., Shapiro, D., Lindor, K. D.


• Increasing Prevalence of Cirrhosis among US Adults with Chronic Hepatitis C Virus Infection: Results from NHANES 1988-1994 and 1999-2012

Udompap, P., Mannalithara, A., Heo, N., Kim, D., Kim, W.


• Etiology-Specific Effect of Diabetes on the Risk of HCC in Patients with Cirrhosis

Yang, J., Mohammed, H., Gores, G. J., Roberts, L. R., Kim, W.


• Heat Mapping Incident PBC Patients in a Large US Laboratory Sample

Lindor, K. D., Mayne, T. J., Swanson, H., Shapiro, D., Kim, W.


• Characteristics of Incident PBC Patients in a Large US Laboratory Sample

Lindor, K. D., Mayne, T. J., Swanson, H., Shapiro, D., Kim, W.


• Policy Implications of Disproportionate Burden of Hepatitis C Care for Medicaid Compared to Commercial Payers

Kim, W., Reau, N., Shiffman, M. L., Cournand, H., Hassanein, T. I.


• Short Sleep Duration is associated with Nonalcoholic Fatty Liver Disease in US Adults

Kim, D., Kim, H., Allen, A. M., Ahmed, A., Heo, N., Udompap, P., Mannalithara, A., Kim, W.


• Serum Cystatin Cas an Indicator of Renal Function and Mortality in Liver Transplant Recipients TRANSPLANTATION

Allen, A. M., Kim, W. R., Larson, J. J., Colby, C., Therneau, T. M., Rule, A. D.

2015; 99 (7): 1431-1435

• Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites (vol62, pg 968, 2015) JOURNAL OF HEPATOLOGY

Angeli, P., Gines, P., Wong, F., Bernardi, M., Boyer, T. D., Gerbes, A., Moreau, R., Jalan, R., Sarin, S. K., Piano, S., Moore, K., Lee, S. S., Durand, et al

2015; 63 (1): 290

• Delayed Hepatocellular Carcinoma Model for End-Stage Liver Disease Exception Score Improves Disparity in Access to Liver Transplant in the UnitedStates HEPATOLOGY

Heimbach, J. K., Hirose, R., Stock, P. G., Schladt, D. P., Xiong, H., Liu, J., Olthoff, K. M., Harper, A., Snyder, J. J., Israni, A. K., Kasiske, B. L., Kim, W. R.

2015; 61 (5): 1643-1650

• A glass half full: Implications of screening for hepatitis C virus in the era of highly effective antiviral therapy. Hepatology

Lutchman, G., Kim, W. R.

2015; 61 (5): 1455-1458

• Long-term Patient and Graft Survival After Kidney Transplantation in Recipients With Hepatitis C Virus Infection

Heo, N., Udompap, P., Mannalithara, A., Kim, W.

WILEY-BLACKWELL.2015

• Age-Dependent Decline in Glomerular Filtration Rate: A US Population-Based Study

Udompap, P., Heo, N., Mannalithara, A., Kim, W.


• Evaluating Outcomes in Multi-Organ Liver Transplant Recipients

Snyder, J., Salkowski, N., Zaun, D., Thompson, B., Zeglin, J., Schladt, D., Lake, J., Kim, W., Israni, A., Kasiske, B.


• Historical Comparison of Projected and Observed Liver Transplants

Pyke, J., Schladt, D., Kim, W., Leppke, S., Lake, J., Gentry, S., Segev, D., Israni, A., Snyder, J.


of 32


• Low Level of Hepatitis B Virus Screening Among Patients Receiving Chemotherapy CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

Wi, C., Loo, N. M., Larson, J. J., Moynihan, T. J., Madde, N. R., Grendahl, D. C., Alberts, S. R., Kim, W. R.

2015; 13 (5): 970-975

• Sofosbuvir and simeprevir combination therapy in the setting of liver transplantation and hemodialysis TRANSPLANT INFECTIOUS DISEASE

Perumpail, R. B., Wong, R. J., Ha, L. D., Pham, E. A., Wang, U., Luong, H., Kumari, R., Daugherty, T. J., Higgins, J. P., Younossi, Z. M., Kim, W. R., Glenn, J. S.,Ahmed, et al

2015; 17 (2): 275-278

• Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites GUT

Angeli, P., Gines, P., Wong, F., Bernardi, M., Boyer, T. D., Gerbes, A., Moreau, R., Jalan, R., Sarin, S. K., Piano, S., Moore, K., Lee, S. S., Durand, et al

2015; 64 (4): 531–37

• Reply to: "Chronic kidney disease (CKD) and NAFLD: Time for awareness and screening'' JOURNAL OF HEPATOLOGY

Allen, A. M., Kim, W., Heimbach, J. K., Rule, A. D.

2015; 62 (4): 984–85

• HCC RISK SCORES: APPLICATION OF THE CU-HCC, GAG-HCC AND PAGE-B SCORES TO CHRONIC HEPATITIS B (CHB) PATIENTSTREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF)

Kim, W. R., Loomba, R., Berg, T., Schall, R., Yee, L., Dinh, P., Flaherty, J. F., Martins, E. B., Jacobson, I., Fung, S., Gurel, S., Buti, M., Marcellin, et al


• THE IMPACT OF METABOLIC SYNDROME ON ALT LEVELS AMONG THE LARGE MULTIETHNIC COHORT OF NORTH AMERICANPATIENTS WITH CHRONIC HEPATITIS B INFECTION ENROLLED IN THE HEPATITIS B RESEARCH NETWORK (HBRN)

Khalili, M., Lombardero, M., Feld, J., Shuhart, M., Chung, R., Terrault, N., Kowdley, K., Lisker-Melman, M., Ghany, M., Kim, W. R., Sanyal, A., Lok, A., HBRN


• ADVANCED FIBROSIS IS COMMON IN INDIVIDUALS WHOSE HEPATITIS C HAS NOT BEEN DIAGNOSED: RESULTS FROM THENATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 2001-2012

Udompap, P., Mannalithara, A., Heo, N., Kim, W. R.


• LOWER RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS TREATED WITH ENTECAVIR: A REACH-BANALYSIS OF THE ENUMERATE STUDY

Ahn, J., Nguyen, M., Lee, H., Lim, J., Pan, C., Te, H., Tran, T., Trinh, H. N., Lau, D., Chu, D., Min, A., Leduc, T., Pillai, et al


• KOREAN VERSION OF A MODEL TO ESTIMATE SURVIVAL IN AMBULATORY PATIENTS WITH HEPATOCELLULAR CARCINOMA (K-MESIAH)

Nam, B. H., Park, J., Jeong, S., Lee, S. S., Yu, A., Kim, B. H., Kim, W. R.


• Characteristics of Adults in the Hepatitis B Research Network in North America Reflect Their Country of Origin and Hepatitis B VirusGenotype CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

Ghany, M. G., Perrillo, R., Li, R., Belle, S. H., Janssen, H. l., Terrault, N. A., Shuhart, M. C., Lau, D. T., Kim, W. R., Fried, M. W., Sterling, R. K., Di Bisceglie, A.M., Han, et al

2015; 13 (1): 183-192

• Reply to: "Chronic kidney disease after liver transplantation'' JOURNAL OF HEPATOLOGY

Allen, A. M., Kim, W., Therneau, T. M., Larson, J. J., Heimbach, J. K., Rule, A. D.

2015; 62 (1): 244–45

• Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club ofAscites. Journal of hepatology

Angeli, P. n., Ginès, P. n., Wong, F. n., Bernardi, M. n., Boyer, T. D., Gerbes, A. n., Moreau, R. n., Jalan, R. n., Sarin, S. K., Piano, S. n., Moore, K. n., Lee, S. S.,Durand, et al

2015; 62 (4): 968–74

• Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B. Cancer


of 32

Kim, W. R., Loomba, R. n., Berg, T. n., Aguilar Schall, R. E., Yee, L. J., Dinh, P. V., Flaherty, J. F., Martins, E. B., Therneau, T. M., Jacobson, I. n., Fung, S. n.,Gurel, S. n., Buti, et al

2015; 121 (20): 3631–38

• OPTN/SRTR 2013 Annual Data Report: liver AMERICAN JOURNAL OF TRANSPLANTATION


2015; 15

• Risk Prediction of Hepatocellular Carcinoma in Patients With Cirrhosis: The ADRESS-HCC Risk Model CANCER

Flemming, J. A., Yang, J. D., Vittinghoff, E., Kim, W. R., Terrault, N. A.

2014; 120 (22): 3485-3493

• Coffee: a panacea or snake oil for the liver? Clinical gastroenterology and hepatology

Kumari, R., Kim, W. R.

2014; 12 (9): 1569-1571

• Chronic kidney disease and associated mortality after liver transplantation - A time-dependent analysis using measured glomerular filtrationrate JOURNAL OF HEPATOLOGY

Allen, A. M., Kim, W. R., Therneau, T. M., Larson, J. J., Heimbach, J. K., Rule, A. D.

2014; 61 (2): 286-292

• Validation of a model to estimate survival in ambulatory patients with hepatocellular carcinoma: a single-centre cohort study LIVER INTERNATIONAL

Kim, B. H., Park, J., Nam, B., Kwak, H. W., Kim, W. R.

2014; 34 (7): E317-E323

• Toward an Improved Definition of Acute-on-Chronic Liver Failure GASTROENTEROLOGY

Jalan, R., Yurdaydin, C., Bajaj, J. S., Acharya, S. K., Arroyo, V., Lin, H., Gines, P., Kim, W., Kamath, P. S., World Gastroenterology Org Working

2014; 147 (1): 4–10

• Effect of the Pretransplant Serum Sodium Concentration on Outcomes Following Liver Transplantation LIVER TRANSPLANTATION

Leise, M. D., Yun, B. C., Larson, J. J., Benson, J. T., Yang, J. D., Therneau, T. M., Rosen, C. B., Heimbach, J. K., Biggins, S. W., Kim, W. R.

2014; 20 (6): 687-697

• Tall, Male, and What Else? Disparities in Liver Transplantation Based On Gender and Height

Allen, A., Kim, W., Larson, J., Heimbach, J., Therneau, T.

WILEY-BLACKWELL.2014: 725

• Center Variation in Graft Failure Rates Is Larger for Simultaneous Liver Kidney Transplantation Than Liver Transplantation Alone.

Asrani, S. K., Saracino, G., Trotter, J., Nadim, M., Kim, W., Jennings, L., Klintmalm, G.

WILEY-BLACKWELL.2014: S278

• Comparative Effectiveness of Telaprevir-Based Triple Therapy in Patients With Chronic Hepatitis C MAYO CLINIC PROCEEDINGS

Al-Bawardy, B., Kim, W. R., Poterucha, J. J., Gross, J. B., Charlton, M. R., Larson, J. J., Colby, C. L., Canterbury, K., Warner, J., Therneau, T. M.

2014; 89 (5): 595-601

• Survival of Recipients of Livers From Donation After Circulatory Death Who Are Relisted and Undergo Retransplant for Graft Failure AMERICANJOURNAL OF TRANSPLANTATION

Allen, A. M., Kim, W. R., Xiong, H., Liu, J., Stock, P. G., Lake, J. R., Chinnakotla, S., Snyder, J. J., Israni, A. K., Kasiske, B. L.

2014; 14 (5): 1120-1128

• LIVER DISEASES UNIQUE TO PREGNANCY - A POPULATION-BASED STUDY

Allen, A. M., Kim, W. R., Rosedahl, J. K., Yawn, B. P., Hay, J. E.


• PREDICTION OF ALT FLARES IN THE NATURAL HISTORY OF CHRONIC HEPATITIS B INFECTION: A PROSPECTIVE COHORT STUDYFROM THE NIDDK HEPATITIS B RESEARCH NETWORK (HBRN)

Brahmania, M., Brouwer, W. P., Perrillo, R., Kim, W. R., Wong, D., Feld, J., Janssen, H., Hepatitis B Res Network


• APRI AND FIB-4 VS HISTOLOGY IN CHB PATIENTS IN TENOFOVIR DISOPROXIL FUMARATE (TDF) CLINICAL TRIALS

Kim, W. R., Berg, T., Asselah, T., Flisiak, R., Fung, S., Gordon, S., Janssen, H. A., Lampertico, P., Lau, D., Bornstein, J. D., Schall, R. A., Dinh, P., Yee, et al


of 32


• The impact of hepatitis C burden: an evidence-based approach ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Younossi, Z. M., Kanwal, F., Saab, S., Brown, K. A., El-Serag, H. B., Kim, W. R., Ahmed, A., Kugelmas, M., Gordon, S. C.

2014; 39 (5): 518-531

• Management of Hepatic Encephalopathy in the Hospital MAYO CLINIC PROCEEDINGS

Leise, M. D., Poterucha, J. J., Kamath, P. S., Kim, W. R.

2014; 89 (2): 241-253

• Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes. Hepatology (Baltimore, Md.)

Zhang, X. n., Harmsen, W. S., Mettler, T. A., Kim, W. R., Roberts, R. O., Therneau, T. M., Roberts, L. R., Chaiteerakij, R. n.

2014

• Safety and Effectiveness of Sofosbuvir (SOF) in Combination with Simeprevir (SIM) or Ribavirin (RBV) for the Treatment of Hepatitis C Virus (HCV)Recurrence after Liver Transplant (LT)

Lutchman, G. A., Nguyen, N. H., Hsiao, T. I., Vu, V. D., Chen, V., Ahmed, A., Daugherty, T., Garcia, G., Kumari, R., Kim, W., Nguyen, M. H.


• Striking differences in wait-listing trends between patients with viral hepatitis B and C: implications of effective anti-viral therapy

Flemming, J. A., Kim, W., Brosgart, C., Terrault, N.


• The effect of long-term use of non-selective beta-blocker on the development of acute kidney injury in patients with liver cirrhosis

Kim, S., Kim, W., Larson, J. J., Kremers, W. K., Kamath, P. S.


• Serum Lysyl Oxidase Like 2 (sLOXL2) Levels Correlate with Ishak Fibrosis Score and Decrease with Treatment with Tenofovir Disoproxil Fumarate(TDF) in Patients with Chronic Hepatitis B (CHB)

Kim, W., Loomba, R., Lal, P., Schall, R., Johnson, A. D., Bornstein, J. D., Subramanian, M., McHutchison, J. G., Harrison, S. A., Sanyal, A. J.


• The Economic Burden and Mortality of Patients with Acute on Chronic Liver Failure (ACLF) in the United States

Allen, A. M., Kim, W., Moriarty, J. P., Shah, N., Kamath, P. S.


• Entecavir Safety and Effectiveness in a National Cohort of Chronic Hepatitis B Patients in the United States - the ENUMERATE study

Ahn, J., Lee, H., Lim, J. K., Pan, C. Q., Nguyen, M. H., Kim, W., Trinh, H. N., Tran, T. T., Chu, D., Min, A., Do, S. T., Woog, J., Mannalithara, et al


• Incidence of Hepatocellular Carcinoma in a National Cohort of Chronic Hepatitis B Patients on Long Term Entecavir Treatment- the ENUMERATEstudy

Ahn, J., Lim, J. K., Lee, H., Pan, C. Q., Nguyen, M. H., Trinh, H. N., Tran, T. T., Chu, D., Min, A., Do, S. T., Woog, J., Mannalithara, A., Lok, et al


• OPTN/SRTR 2012 Annual Data Report: liver AMERICAN JOURNAL OF TRANSPLANTATION

Kim, W. R., Smith, J. M., Skeans, M. A., Schladt, D. P., Schnitzler, M. A., Edwards, E. B., Harper, A. M., Wainright, J. L., Snyder, J. J., Israni, A. K., Kasiske, B.L.

2014; 14: 69–96

• Efficacy and Safety of Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

Allen, A. M., Kim, W. R., Larson, J., Loftus, E. V.

2013; 11 (12): 1655-U321

• Risk Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis: The ADRESS-HCC Risk Model 64th Annual Meeting and Postgraduate Course ofthe American-Association-for-the-Study-of-Liver-Diseases

Flemming, J. A., Vittinghoff, E., Kim, W. R., Terrault, N.


• Impact of the center on graft failure after liver transplantation LIVER TRANSPLANTATION

Asrani, S. K., Kim, W. R., Edwards, E. B., Larson, J. J., Thabut, G., Kremers, W. K., Therneau, T. M., Heimbach, J.


of 32

2013; 19 (9): 957-964

• Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: Noninvasive Assessment with MR Elastography RADIOLOGY

Kim, D., Kim, W. R., Talwalkar, J. A., Kim, H. J., Ehman, R. L.

2013; 268 (2): 411-419

• Underestimation of Liver-Related Mortality in the United States GASTROENTEROLOGY

Asrani, S. K., Larson, J. J., Yawn, B., Therneau, T. M., Kim, W. R.

2013; 145 (2): 375-?

• Hepatitis B Screening and Vaccination Practices in Asian American Primary Care GUT AND LIVER

Chu, D., Yang, J. D., Lok, A. S., Tram Tran, T., Martins, E. B., Fagan, E., Rousseau, F., Kim, W. R.

2013; 7 (4): 450-457

• Excellent quality of life after liver transplantation for patients with perihilar cholangiocarcinoma who have undergone neoadjuvantchemoradiation LIVER TRANSPLANTATION

Murad, S. D., Heimbach, J. K., Gores, G. J., Rosen, C. B., Benson, J. T., Kim, W. R.

2013; 19 (5): 521-528

• Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States HEPATOLOGY

Kim, D., Kim, W. R., Kim, H. J., Therneau, T. M.

2013; 57 (4): 1357-1365

• Predicting clinical outcomes with elastography in primary biliary cirrhosis: one step closer? Gastroenterology

Singh, S., Kim, W. R., Talwalkar, J. A.

2013; 144 (4): 851-852

• Risk Factors for Intrahepatic Cholangiocarcinoma: Association Between Metformin Use and Reduced Cancer Risk HEPATOLOGY

Chaiteerakij, R., Yang, J. D., Harmsen, W. S., Slettedahl, S. W., Mettler, T. A., Fredericksen, Z. S., Kim, W. R., Gores, G. J., Roberts, R. O., Olson, J. E., Therneau,T. M., Roberts, L. R.

2013; 57 (2): 648-655

• Assessing the cost utility of response-guided therapy in patients with chronic hepatitis C genotype 1 in the UK using the MONARCH model. Applied healtheconomics and health policy

McEwan, P., Kim, R., Yuan, Y.

2013; 11 (1): 53-63


Kim, W. R., Stock, P. G., Smith, J. M., Heimbach, J. K., Skeans, M. A., Edwards, E. B., Harper, A. M., Snyder, J. J., Israni, A. K., Kasiske, B. L.

2013; 13: 73-102

• Kidney, Pancreas and Liver Allocation and Distribution in the United States AMERICAN JOURNAL OF TRANSPLANTATION

Smith, J. M., Biggins, S. W., Haselby, D. G., Kim, W. R., Wedd, J., Lamb, K., Thompson, B., Segev, D. L., Gustafson, S., Kandaswamy, R., Stock, P. G., Matas, A.J., Samana, et al

2012; 12 (12): 3191-3212

• Simultaneous Liver-Kidney Transplantation Summit: Current State and Future Directions AMERICAN JOURNAL OF TRANSPLANTATION

Nadim, M. K., Sung, R. S., Davis, C. L., Andreoni, K. A., Biggins, S. W., Danovitch, G. M., Feng, S., Friedewald, J. J., Hong, J. C., Kellum, J. A., Kim, W. R.,Lake, J. R., Melton, et al

2012; 12 (11): 2901-2908

• Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma HEPATOLOGY

Murad, S. D., Kim, W. R., Therneau, T., Gores, G. J., Rosen, C. B., Martenson, J. A., Alberts, S. R., Heimbach, J. K.

2012; 56 (3): 972-981

• Biliary Tract Cancers in Olmsted County, Minnesota, 1976-2008 AMERICAN JOURNAL OF GASTROENTEROLOGY

Yang, J. D., Kim, B., Sanderson, S. O., St Sauver, J., Yawn, B. P., Larson, J. J., Therneau, T. M., Roberts, L. R., Gores, G. J., Kim, W. R.

2012; 107 (8): 1256-1262

• Model to estimate survival in ambulatory patients with hepatocellular carcinoma HEPATOLOGY


of 32

Yang, J. D., Kim, W. R., Park, K. W., Chaiteerakij, R., Kim, B., Sanderson, S. O., Larson, J. J., Pedersen, R. A., Therneau, T. M., Gores, G. J., Roberts, L. R., Park,J.

2012; 56 (2): 614-621

• Nonalcoholic fatty liver disease is associated with coronary artery calcification HEPATOLOGY

Kim, D., Choi, S., Park, E. H., Lee, W., Kang, J. H., Kim, W., Kim, Y. J., Yoon, J., Jeong, S. H., Lee, D. H., Lee, H., Larson, J., Therneau, et al

2012; 56 (2): 605-613

• Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology

Darwish Murad, S., Kim, W. R., Harnois, D. M., Douglas, D. D., Burton, J., Kulik, L. M., Botha, J. F., Mezrich, J. D., Chapman, W. C., Schwartz, J. J., Hong, J. C.,Emond, J. C., Jeon, et al

2012; 143 (1): 88-98 e3

• Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 USCenters GASTROENTEROLOGY

Murad, S. D., Kim, W. R., Harnois, D. M., Douglas, D. D., Burton, J., Kulik, L. M., Botha, J. F., Mezrich, J. D., Chapman, W. C., Schwartz, J. J., Hong, J. C.,Emond, J. C., Jeon, et al

2012; 143 (1): 88-U610

• Hospitalization for Underage Drinkers in the United States JOURNAL OF ADOLESCENT HEALTH

Kim, J. Y., Asrani, S. K., Shah, N. D., Kim, W. R., Schneekloth, T. D.

2012; 50 (6): 648-650

• Evaluation of Elevated Liver Enzymes CLINICS IN LIVER DISEASE

Lee, T. H., Kim, W. R., Poterucha, J. J.

2012; 16 (2): 183-?

• Development of organ-specific donor risk indices LIVER TRANSPLANTATION

Akkina, S. K., Asrani, S. K., Peng, Y., Stock, P., Kim, W. R., Israni, A. K.

2012; 18 (4): 395-404

• Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: Asystematic review and meta-analysis LIVER TRANSPLANTATION

Adebajo, C. O., Talwalkar, J. A., Poterucha, J. J., Kim, W., Charlton, M. R.

2012; 18 (3): 323–31

• Nonalcoholic fatty liver disease associated with coronary artery calcification Hepatology

Kim, D., Choi, S., Park, E., Lee, W., Kang, J., Kim, W., Kim, Y., Yoon, J., Jeong, S., Lee, D., Lee, H., Larson, J., Therneau, et al

2012; 56 (2): 605-613

• Report on a single-topic conference on "Chronic viral hepatitis--strategies to improve effectiveness of screening and treatment". Hepatology

Ward, J. W., Lok, A. S., Thomas, D. L., El-Serag, H. B., Kim, W. R.

2012; 55 (1): 307-315

• Hepatocellular Carcinoma in Olmsted County, Minnesota, 1976-2008 MAYO CLINIC PROCEEDINGS

Yang, J. D., Kim, B., Sanderson, S. O., St Sauver, J. L., Yawn, B. P., Pedersen, R. A., Larson, J. J., Therneau, T. M., Roberts, L. R., Kim, W. R.

2012; 87 (1): 9-16

• Surveillance for Hepatocellular Carcinoma in Patients With Cirrhosis CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

Yang, J. D., Kim, W. R.

2012; 10 (1): 16-21

• Model for End-Stage Liver Disease: End of the First Decade CLINICS IN LIVER DISEASE

Asrani, S. K., Kim, W. R.

2011; 15 (4): 685-?

• Drug therapy: Telaprevir HEPATOLOGY

Leise, M. D., Kim, W. R., Canterbury, K. M., Poterucha, J. J.

2011; 54 (4): 1463-1469

• Factors That Affect Risk for Hepatocellular Carcinoma and Effects of Surveillance CLINICAL GASTROENTEROLOGY AND HEPATOLOGY


of 32

Yang, J. D., Harmsen, W. S., Slettedahl, S. W., Chaiteerakij, R., Enders, F. T., Therneau, T. M., Orsini, L., Kim, W. R., Roberts, L. R.

2011; 9 (7): 617-U141

• A Revised Model for End-Stage Liver Disease Optimizes Prediction of Mortality Among Patients Awaiting Liver Transplantation GASTROENTEROLOGY

Leise, M. D., Kim, W. R., Kremers, W. K., Larson, J. J., Benson, J. T., Therneau, T. M.

2011; 140 (7): 1952-1960

• Born to be wild or just confused? Genetic predisposition to hepatic encephalopathy. Gastroenterology

Duarte-Rojo, A., Kamath, P. S., Kim, W. R.

2011; 140 (7): 2137-2138

• Many Patients With Primary Sclerosing Cholangitis and Increased Serum Levels of Carbohydrate Antigen 19-9 Do Not HaveCholangiocarcinoma CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

Sinakos, E., Saenger, A. K., Keach, J., Kim, W. R., Lindor, K. D.

2011; 9 (5): 434-U1433

• Cirrhosis Is Present in Most Patients With Hepatitis B and Hepatocellular Carcinoma CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

Yang, J. D., Kim, W. R., Coelho, R., Mettler, T. A., Benson, J. T., Sanderson, S. O., Therneau, T. M., Kim, B., Roberts, L. R.

2011; 9 (1): 64-70

• Treatment of Hepatitis B Virus-Associated Nephropathy NEPHRON CLINICAL PRACTICE

Elewa, U., Sandri, A. M., Kim, W. R., Fervenza, F. C.

2011; 119 (1): C41-C49

• The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities. Journal of medical economics

DiBonaventura, M. D., Wagner, J., Yuan, Y., L'Italien, G., Langley, P., Ray Kim, W.

2011; 14 (2): 253-261

• Utility of Serum YKL-40 as a Tumor-Specific Marker of Hepatobiliary Malignancies GUT AND LIVER

Yang, J. D., Kim, E., Pedersen, R. A., Kim, W. R., Pungpapong, S., Roberts, L. R.

2010; 4 (4): 537-542

• Impact of MELD on Waitlist Outcome of Retransplant Candidates AMERICAN JOURNAL OF TRANSPLANTATION

Kim, H. J., Larson, J. J., Lim, Y. S., Kim, W. R., Pedersen, R. A., Therneau, T. M., Rosen, C. B.

2010; 10 (12): 2652-2657

• Use of Sirolimus in Liver Transplant Recipients with Renal Insufficiency: A Systematic Review and Meta-Analysis HEPATOLOGY

Asrani, S. K., Leise, M. D., West, C. P., Murad, M. H., Pedersen, R. A., Erwin, P. J., Tian, J., Wiesner, R. H., Kim, W. R.

2010; 52 (4): 1360-1370

• Rifaximin in hepatic encephalopathy: is an ounce of prevention worth a pretty penny? Gastroenterology

Leise, M. D., Kim, W. R.

2010; 139 (4): 1416-1418

• Daclizumab induction therapy in liver transplant recipients with renal insufficiency ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Asrani, S. K., Kim, W. R., Pedersen, R. A., Charlton, M. R., Kremers, W. K., Therneau, T. M., Rosen, C. B., Dean, P. G.

2010; 32 (6): 776-786

• Endothelial Nitric Oxide Synthase Gene Variation Associated With Chronic Kidney Disease After Liver Transplant MAYO CLINIC PROCEEDINGS

Bambha, K., Kim, W. R., Rosen, C. B., Pedersen, R. A., Rys, C., Kolbert, C. P., Cunningham, J. M., Therneau, T. M.

2010; 85 (9): 814-820

• Impact of Depressive Symptoms and Their Treatment on Completing Antiviral Treatment in Patients With Chronic Hepatitis C JOURNAL OF CLINICALGASTROENTEROLOGY

Liu, S. S., Schneekloth, T. D., Talwalkar, J. A., Kim, W. R., Poterucha, J. J., Charlton, M. R., Wiesner, R. H., Gross, J. B.

2010; 44 (8): E178-E185

• Alcoholic Liver Disease-Related Mortality in the United States: 1980-2003 AMERICAN JOURNAL OF GASTROENTEROLOGY

Paula, H., Asrani, S. K., Boetticher, N. C., Pedersen, R., Shah, V. H., Kim, W. R.

2010; 105 (8): 1782-1787


of 32

• Donor Race Does Not Predict Graft Failure After Liver Transplantation GASTROENTEROLOGY

Asrani, S. K., Lim, Y., Therneau, T. M., Pedersen, R. A., Heimbach, J., Kim, W. R.

2010; 138 (7): 2341-2347

• Organ allocation for chronic liver disease: model for end-stage liver disease and beyond CURRENT OPINION IN GASTROENTEROLOGY

Asrani, S. K., Kim, W. R.

2010; 26 (3): 209-213

• Serum sodium, renal function, and survival of patients with end-stage liver disease JOURNAL OF HEPATOLOGY

Lim, Y., Larson, T. S., Benson, J. T., Kamath, P. S., Kremers, W. K., Therneau, T. M., Kim, W. R.

2010; 52 (4): 523-528

• Reports from today's health care environment on the implementation of screening, diagnosis, and treatment recommendations JOURNAL OF FAMILYPRACTICE

Kim, W. R., Valdiserri, R. O., Wright, L. N., Manos, M. M., Do, S. T.

2010; 59 (4): S43-S49

• Transforming the current infrastructure for combating HBV and HCV infections JOURNAL OF FAMILY PRACTICE

Kim, W. R., Ward, J. W., Cheever, L. W., Dan, C., Dee, L., Zola, J.

2010; 59 (4): S65-S70

• Humanistic and economic impacts of hepatitis C infection in the United States. Journal of medical economics

DiBonaventura, M. D., Wagner, J., Yuan, Y., L'Italien, G., Langley, P., Ray Kim, W.

2010; 13 (4): 709-718

• Trends in Waiting List Registration for Liver Transplantation for Viral Hepatitis in the United States GASTROENTEROLOGY

Kim, W. R., Terrault, N. A., Pedersen, R. A., Therneau, T. M., Edwards, E., Hindman, A. A., Brosgart, C. L.

2009; 137 (5): 1680-1686

• Hepatitis C Nonresponders: Re-treat or Retreat? HEPATOLOGY

Leise, M., Kim, W. R.

2009; 50 (4): 1307-1309

• Increased Prevalence and Mortality in Undiagnosed Celiac Disease GASTROENTEROLOGY

Rubio-tapia, A., Kyle, R. A., Kaplan, E. L., Johnson, D. R., Page, W., Erdtmann, F., Brantner, T. L., Kim, W. R., Phelps, T. K., Lahr, B. D., Zinsmeister, A. R.,Melton, L. J., Murray, et al

2009; 137 (1): 88-93

• Impact of Pretransplant Hyponatremia on Outcome Following Liver Transplantation HEPATOLOGY

Yun, B. C., Kim, W. R., Benson, J. T., Biggins, S. W., Therneau, T. M., Kremers, W. K., Rosen, C. B., Klintmalm, G. B.

2009; 49 (5): 1610-1615

• Epidemiology of Hepatitis B in the United States HEPATOLOGY

Kim, W. R.

2009; 49 (5): S28-S34

• The International Normalized Ratio of Prothrombin Time in the Model for End-Stage Liver Disease Score: A Reliable Measure CLINICS IN LIVERDISEASE

Kamath, P. S.

2009; 13 (1): 63-?

• The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease CLINICS IN LIVER DISEASE

Lim, Y., Kim, W. R.

2008; 12 (4): 733-?

• Hyponatremia and mortality among patients on the liver-transplant waiting list NEW ENGLAND JOURNAL OF MEDICINE

Kim, W. R., Biggins, S. W., Kremers, W. K., Wiesner, R. H., Kamath, P. S., Benson, J. T., Edwards, E., Therneau, T. M.

2008; 359 (10): 1018-1026

• Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis GUT


of 32

Bambha, K., Kim, W. R., Pedersen, R., Bida, J. P., Kremers, W. K., Kamath, P. S.

2008; 57 (6): 814-820

• Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease HEPATOLOGY

Kim, W. R., Flamm, S. L., Di Bisceglie, A. M., Bodenheimer, H. C.

2008; 47 (4): 1363-1370

• Mortality attributable to cholestatic liver disease in the United States HEPATOLOGY

Mendes, F. D., Kim, W. R., Pedersen, R., Therneau, T., Lindor, K. D.

2008; 47 (4): 1241-1247

• Serum aminotransferase activity and mortality risk in a United States community HEPATOLOGY

Lee, T. H., Kim, W. R., Benson, J. T., Therneau, T. M., Melton, L. J.

2008; 47 (3): 880-887

• Mortality in patients with hepatitis C. Gastroenterology

Pungpapong, S., Kim, W. R.

2008; 134 (2): 635-637

• Survival after liver transplantation: is racial disparity inevitable? HEPATOLOGY

Lee, T. H., Shah, N., Pedersen, R. A., Kremers, W. K., Rosen, C. B., Klintmalm, G. B., Kim, W. R.

2007; 46 (5): 1491-1497

• Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease LIVER TRANSPLANTATION

Stewart, C. A., Malinchoc, M., Kim, W. R., Kamath, P. S.

2007; 13 (10): 1366-1371

• Natural history of hepatitis B virus infection: An update for clinicians MAYO CLINIC PROCEEDINGS

Pungpapong, S., Kim, W. R., Poterucha, J. J.

2007; 82 (8): 967-975

• Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome? LIVER TRANSPLANTATION

Murad, S. D., Kim, W. R., de Groen, P. C., Kamath, P. S., Malinchoc, M., Valla, D., Janssen, H. l.

2007; 13 (6): 867-874

• Risk factors for mortality after surgery in patients with cirrhosis GASTROENTEROLOGY

Teh, S. H., Nagorney, D. M., Stevens, S. R., Offord, K. P., Therneau, T. M., Plevak, D. J., Talwalkar, J. A., Kim, W. R., Kamath, P. S.

2007; 132 (4): 1261-1269

• The Model for End-stage Liver Disease (MELD) HEPATOLOGY

Kamath, P. S., Kim, W. R.

2007; 45 (3): 797-805

• Is coffee or tea good for your liver? NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY

Kim, W. R.

2006; 3 (9): 482-483

• Evidence-based incorporation of serum sodium concentration into MELD GASTROENTEROLOGY

Biggins, S. W., Kim, W. R., Terrault, N. A., Saab, S., Balan, V., Schiano, T., Benson, J., Therneau, T., Kremers, W., Wiesner, R., Kamath, P., Klintmalm, G.

2006; 130 (6): 1652-1660

• Deaths on the liver transplant waiting list: An analysis of competing risks HEPATOLOGY

Kim, W. R., Therneau, T. M., Benson, J. T., Kremers, W. K., Rosen, C. B., Gores, G. J., Dickson, E. R.

2006; 43 (2): 345-351

• Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of end-stage liver disease (MELD) score predicts perioperativemortality JOURNAL OF GASTROINTESTINAL SURGERY

Teh, S. H., Christein, J., Donohue, J., QUE, F., Kendrick, M., Farnell, M., Cha, S., Kamath, P., Kim, R., Nagorney, D. M.

2005; 9 (9): 1207-1215


of 32

• Mortality and hospital utilization for hepatocellular carcinoma in the United States GASTROENTEROLOGY

Kim, W. R., Gores, G. J., Benson, J. T., Therneau, T. M., Melton, L. J.

2005; 129 (2): 486-493

• Employment and health insurance in long-term liver transplant recipients AMERICAN JOURNAL OF TRANSPLANTATION

Rongey, C., Bambha, K., Vanness, D., Pedersen, R. A., Malinchoc, M., Therneau, T. M., Dickson, E. R., Kim, W. R.

2005; 5 (8): 1901-1908

• The use of decision analytic models to inform clinical decision making in the management of hepatocellular carcinoma. Clinics in liver disease

Kim, W. R.

2005; 9 (2): 225-234

• MELD accurately predicts mortality in patients with alcoholic hepatitis HEPATOLOGY

Dunn, W., Jamil, L. H., Brown, L. S., Wiesner, R. H., Kim, W. R., Menon, K. V., Malinchoc, M., Kamath, P. S., Shah, V.

2005; 41 (2): 353-358

• Predicting survival among patients listed for liver transplantation: An assessment of serial MELD measurements AMERICAN JOURNAL OFTRANSPLANTATION

Bambha, K., Kim, W. R., Kremers, W. K., Therneau, T. M., Kamath, P. S., Wiesner, R., Rosen, C. B., Thostenson, J., Benson, J. T., Dickson, E. R.

2004; 4 (11): 1798-1804

• The impact of competing risks on the observed rate of chronic hepatitis C progression GASTROENTEROLOGY

Kim, W. R., Poterucha, J. J., Benson, J. T., Therneau, T. M.

2004; 127 (3): 749-755

• Outcome of liver transplantation for hepatitis B in the United States LIVER TRANSPLANTATION

Kim, W. R., Poterucha, J. J., Kremers, W. K., Ishitani, M. B., Dickson, E. R.

2004; 10 (8): 968-974

• Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Bambha, K., Kim, W. R.

2004; 16 (6): 519-526

• Measurement of ionizing radiation using carbon nanotube field effect transistor 46th Annual Meeting of the American-Association-of-Physicists-in-Medicine

Tang, X., Yang, Y., Kim, W., Wang, Q., Xing, L., Dai, H.

AMER ASSOC PHYSICISTS MEDICINE AMER INST PHYSICS.2004: 1839–39

• Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae? JOURNAL OF HEPATOLOGY

Abdulkarim, A. S., Petrovic, L. M., Kim, W. R., Angulo, P., Lloyd, R. V., Lindor, K. D.

2004; 40 (3): 380-384

• Management of patients with hepatitis C in a community population: Diagnosis, discussions, and decisions to treat ANNALS OF FAMILY MEDICINE

Rocca, L. G., Yawn, B. P., Wollan, P., Kim, W. R.

2004; 2 (2): 116-124

• MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS Status 1 patients HEPATOLOGY

Kremers, W. K., van Ijperen, M., Kim, W. R., Freeman, R. B., Harper, A. M., Kamath, P. S., Wiesner, R. H.

2004; 39 (3): 764-769

• Changing epidemiology of hepatitis B in a US community HEPATOLOGY

Kim, W. R., Benson, J. T., Therneau, T. M., Torgerson, H. A., Yawn, B. P., Melton, L. J.

2004; 39 (3): 811-816

• Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community GASTROENTEROLOGY

Bambha, K., Kim, W. R., Talwalkar, J., Torgerson, H., Benson, J. T., Therneau, T. M., Loftus, E. V., Yawn, B. P., Dickson, E. R., Melton, L. J.

2003; 125 (5): 1364-1369

• Effect of minimal listing criteria on waiting list registration for liver transplantation: A process-outcome analysis 51st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases

Talwalkar, J. A., Kim, W. R., Rosen, C. B., Kamath, P. S., Wiesner, R. H.


of 32

MAYO CLINIC PROCEEDINGS.2003: 431–35

• Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites HEPATOLOGY

Evans, L. T., Kim, W. R., Poterucha, J. J., Kamath, P. S.

2003; 37 (4): 897-901

• The burden of hepatitis C in the United States HEPATOLOGY

Kim, W. R.

2002; 36 (5): S30-S34

• Global epidemiology and burden of hepatitis C MICROBES AND INFECTION

Kim, W. R.

2002; 4 (12): 1219-1225

• Rising burden of Hepatitis B in the United States should 'the other' virus be forgotten?.

Kim, W. R., Ishitani, M. R., Dickson, E. R.

W B SAUNDERS CO.2002: 222A

• Motion - The available treatments for hepatitis C are cost effective: Arguments against the motion CANADIAN JOURNAL OF GASTROENTEROLOGY

Kim, W. R.

2002; 16 (10): 710-715

• Bayesian estimation, simulation and uncertainty analysis: the cost-effectiveness of ganciclovir prophylaxis in liver transplantation HEALTH ECONOMICS

Vanness, D. J., Kim, W. R.

2002; 11 (6): 551-566

• Medical and economic impact of autoimmune hepatitis. Clinics in liver disease

Talwalkar, J. A., Kim, W. R.

2002; 6 (3): 649-667

• Burden of liver disease in the United States: Summary of a workshop HEPATOLOGY

Kim, W. R., Brown, R. S., Terrault, N. A., El-Serag, H.

2002; 36 (1): 227-242

• Development and maintenance of a community-based hepatitis C registry AMERICAN JOURNAL OF MANAGED CARE

Yawn, B. P., Gazzuola, L., Wollan, P. C., Kim, W. R.

2002; 8 (3): 253-261

• Diagnosis and 10-year follow-up of a community-based hepatitis C cohort JOURNAL OF FAMILY PRACTICE

Yawn, B. P., Wollan, P., Gazzuola, L., Kim, W. R.

2002; 51 (2): 135-140

• Is it time for mass screening for hepatitis C? AMERICAN JOURNAL OF MEDICINE

Kim, W. R., Poterucha, J. J.

2001; 111 (8): 667–68

• Treatment of hepatitis C cirrhosis using pegylated interferon: Money well spent?.

Kim, W. R., Poterucha, J. J.


• Determinants of death on liver transplant waiting list: Waiting time, blood group or MELD?

Kim, W. R., Kremers, W. K., Malinchoc, M., Rosen, C. B., Dickson, E. R.


• Prediction of liver transplant outcome based on pretransplant disease severity: Is there anything better than MELD?

Wiesner, R. H., Kim, W. R., Malinchoc, M., Kamath, P. S., Kremers, W. K., Weinstein, J. S., Klintmalm, G. B., Krom, R. A.


• MELD and PELD: Application of survival models to liver allocation LIVER TRANSPLANTATION

Wiesner, R. H., McDiarmid, S. V., Kamath, P. S., Edwards, E. B., Malinchoc, M., Kremers, W. K., Krom, R. A., Kim, W. R.


of 32

2001; 7 (7): 567-580

• A model to predict survival in patients with end-stage liver disease HEPATOLOGY

Kamath, P. S., Wiesner, R. H., Malinchoc, M., Kremers, W., Therneau, T. M., Kosberg, C. L., D'Amico, G., Dickson, E. R., Kim, W. R.

2001; 33 (2): 464-470

• Outcome of hospital care of liver disease associated with hepatitis C in the United States HEPATOLOGY

Kim, W. R., Gross, J. B., Poterucha, J. J., Locke, G. R., Dickson, E. R.

2001; 33 (1): 201-206

• Epidemiology and natural history of primary biliary cirrhosis in a US community GASTROENTEROLOGY

Kim, W. R., Lindor, K. D., Locke, G. R., Therneau, T. M., Homburger, H. A., Batts, K. P., Yawn, B. P., Petz, J. L., Melton, L. J., Dickson, E. R.

2000; 119 (6): 1631-1636

• Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liverdisease HEPATOLOGY

Kim, W. R., Lindor, K. D., Malinchoc, M., Petz, J. L., Jorgensen, R., Dickson, E. R.

2000; 32 (5): 924-929

• Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score LIVERTRANSPLANTATION

Talwalkar, J. A., Seaberg, E., Kim, W. R., Wiesner, R. H.

2000; 6 (6): 753-758

• A revised natural history model for primary sclerosing cholangitis MAYO CLINIC PROCEEDINGS

Kim, W. R., Therneau, T. M., Wiesner, R. H., Poterucha, J. J., Benson, J. T., Malinchoc, M., LaRusso, N. F., Lindor, K. D., Dickson, E. R.

2000; 75 (7): 688-694

• Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates LIVER TRANSPLANTATION

Kim, W. R., Krowka, M. J., Plevak, D. J., Lee, J., Rettke, S. R., Frantz, R. P., Wiesner, R. H.

2000; 6 (4): 453-458

• Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates LIVER TRANSPLANTATION

Kim, W. R., Wiesner, R. H., Poterucha, J. J., Therneau, T. M., Benson, J. T., Krom, R. A., Dickson, E. R.

2000; 6 (4): 489-494

• Particle weakening in superplastic SiC/2124 Al composites at high temperature ACTA MATERIALIA

Kim, W. J., Sherby, O. D.

2000; 48 (8): 1763-1774

• Variant forms of cholestatic diseases involving small bile ducts in adults AMERICAN JOURNAL OF GASTROENTEROLOGY

Kim, W. R., Ludwig, J., Lindor, K. D.

2000; 95 (5): 1130-1138

• The economic impact of cytomegalovirus infection after liver transplantation TRANSPLANTATION

Kim, W. R., Badley, A. D., Wiesner, R. H., Porayko, M. K., Seaberg, E. C., Keating, M. R., Evans, R. W., Dickson, E. R., Krom, R. A., Paya, C. V.

2000; 69 (3): 357-361

• Timing of liver transplantation SEMINARS IN LIVER DISEASE

Kim, W. R., Dickson, E. R.

2000; 20 (4): 451-464

• Hepatic retransplantation in cholestatic liver disease: Impact of the interval to retransplantation on survival and resource utilization HEPATOLOGY

Kim, W. R., Wiesner, R. H., Poterucha, J. J., Therneau, T. M., Malinchoc, M., Benson, J. T., Crippin, J. S., Klintmalm, G. B., Rakela, J., Starzl, T. E., Krom, R. A.,Evans, R. W., Dickson, et al

1999; 30 (2): 395-400

• The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosingcholangitis HEPATOLOGY

Kim, W. R., Poterucha, J. J., Wiesner, R. H., LaRusso, N. F., Lindor, K. D., Petz, J., Therneau, T. M., Malinchoc, M., Dickson, E. R.

1999; 29 (6): 1643-1648


of 32

• The clinical significance of simultaneous infection with hepatitis G virus in patients with chronic hepatitis C AMERICAN JOURNAL OFGASTROENTEROLOGY

Brandhagen, D. J., Gross, J. B., Poterucha, J. J., Charlton, M. R., Detmer, J., Kolberg, J., Gossard, A. A., Batts, K. P., Kim, W. R., Germer, J. J., Wiesner, R. H.,Persing, D. H.

1999; 94 (4): 1000-1005

• Quality of life before and after liver transplantation for cholestatic liver disease HEPATOLOGY

Gross, C. R., Malinchoc, M., Kim, W. R., Evans, R. W., Wiesner, R. H., Petz, J. L., Crippin, J. S., Klintmalm, G. B., Levy, M. F., Ricci, P., Therneau, T. M.,Dickson, E. R.

1999; 29 (2): 356-364

• Liver transplantation for primary sclerosing cholangitis in the 90's: Patient survival and resource utilization.

Kim, W. R., Wiesner, K. H., Therneau, T. M., Malinchoc, M., Krom, R. A., Evans, R. W., Dickson, E. R., Crippin, J. S., Klintmalm, G. B., Rakela, J., Starzl, T. E.


• Cost-effectiveness of interferon/ribavirin treatment among nonresponders to initial interferon therapy for chronic hepatitis C.

Kim, W. R., Poterucha, J. J., Dickson, E. R., Gross, J. B.


• Moderate to severe portopulmonary hypertension: Important correlates with Doppler echocardiography in liver transplant candidates.

Kim, W. R., Krowka, M. J., Plevak, D. J., Lee, J. H., Rettke, Frantz, R. F., Wiesner, R. H.


• Optimal timing of liver transplantation for primary biliary cirrhosis HEPATOLOGY

Kim, W. R., Wiesner, R. H., Therneau, T. M., Poterucha, J. J., Porayko, M. K., Evans, R. W., Klintmalm, G. B., Crippin, J. S., Krom, R. A., Dickson, E. R.

1998; 28 (1): 33-38

• Predictive models of natural history in primary biliary cirrhosis. Clinics in liver disease


1998; 2 (2): 313-?

• Economic analysis of interferon/ribaviran treatment in patients with chronic hepatitis C who relapse following initial interferon therapy

Kim, W. R., Poterucha, J. J., Dickson, E. R., Gross, J. B.

W B SAUNDERS CO.1998: A1274

• The Mayo risk score increases rapidly in the terminal phase of primary sclerosing cholangitis

Kim, W. R., Lindor, K. D., Poterucha, J. J., Benson, J. T., Therneau, T. M., Dickson, E. R.

W B SAUNDERS CO.1998: A1274

• Does open access to colonoscopy affect its diagnostic yield?

Kim, W. R., Locke, G. R., Evans, R. W., Zinsmeister, A. R., Gostout, C. J.

W B SAUNDERS CO.1998: A22–A23

• Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C ANNALS OF INTERNAL MEDICINE

Kim, W. R., Poterucha, J. J., Hermans, J. E., Therneau, T. M., Dickson, E. R., Evans, R. W., Gross, J. B.

1997; 127 (10): 866-?

• The role of prognostic models in the timing of liver transplantation. Application in cholestatic liver diseases. Clinics in liver disease


1997; 1 (2): 263-?

• Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapyand liver transplantation HEPATOLOGY

Kim, W. R., Poterucha, J. J., Jorgensen, R. A., Batts, K. P., Homburger, H. A., Dickson, E. R., Krom, R. A., Wiesner, R. H., Lindor, K. D.

1997; 26 (1): 22-26

• Should Helicobacter pylori be eradicated prior to initiation of a proton pump inhibitor for gastroesophageal reflux disease?

Kim, W. R., Locke, G. R.

W B SAUNDERS CO-ELSEVIER INC.1997: A22


of 32

• Recurrence of nonalcoholic steatohepatitis following liver transplantation TRANSPLANTATION

Kim, W. R., Poterucha, J. J., Porayko, M. K., Dickson, E. R., Steers, J. L., Wiesner, R. H.

1996; 62 (12): 1802-1805

• Quantifying the role of H-pylori in gastric carcinogenesis: An accelerated failure time model

Kim, W. R., Therneau, T. M., Locke, G. R., Dickson, E. R.

W B SAUNDERS CO-ELSEVIER INC.1996: A156

• Preoperative predictors of resource utilization in liver transplantation. Clinical transplants

Kim, W. R., Therneau, T. M., Dickson, E. R., Evans, R. W.

1995: 315-322

PRESENTATIONS

• Timing of Liver Transplantation for Primary Sclerosing Cholangitis - Annual Meeting of the American Association for the Study of Liver Diseases (11/1998)

• Hepatitis C: Diagnosis, Treatment and Prevention - Olmsted Medical Group (3/1999)

• Natural History of Hepatitis C: Host, Viral and Sociodemographic Factors of Disease Progression - Annual Symposium of Hepatitis C. (6/1999)

• What Is New With Viral Hepatitis: An Update on Hepatitis C - University of Rochester (10/1999)

• Sociodemographic Determinants of the Outcome of Hepatitis C - Conference on Health Policy and Outcomes Research, American Statistical Associate (12/1999)

• Survival Models for Liver Transplant Recipients - Mount Sinai Hospital (4/2000)

• Outcome of Hospitalization Care of Hepatitis in the United States - Mount Sinai Hospital (4/2000)

• Cost-Effectiveness Analysis Research Workshop - American Association of the Study of Liver Diseases (5/2000)

• Cost-Effectiveness Analysis Research Workshop - AASLD (5/2000)

• The New MELD/PELD System Hepatology Update (1/2004)

• Advances in the Treatment of Hepatitis B - Gilead Sciences Lecture Series (4/2004)

• Epidemiology & Prevention - AASLD (10/2004)

• Risk Models & Liver Allocation - AASLD (10/2004)

• Epidemiology of Chronic Hepatitis B Infection - Think B Leadership Conference (11/2004)

• Prognostic Markers for Assessment of Severity of Liver Disease: The Mess if Boiling? - APASL (2/2004)

• Chronic Hepatitis B in the API Community - AHF Lecture Series (10/2007)

• Decline in the need for Liver Transplantation for End Stage Liver Disease Secondary to Hepatitis B in the US - AASLD (11/2007)

• Hepatitis B - Post AASLD Course (12/2007)

• Hepatitis B in the Asian Community - APAMSA (1/2008)

• Utilizing Predictors to Optimize Patient Outcome - APASL (3/2008)

• Hepatitis B: Treatment--#Experience Patients - Update in Hepatology (4/2008)

• Epidemiology and Natural History of HBV - DDW (5/2008)

• Value of Antiviral Therapies in Chronic Hepatitis B - BMS Symposium (6/2008)

• Definition and Significance of Normal and Abnormal Serum - ILC (6/2008)

• Hyponatremia and Liver Transplantation - Single Topic Conference (9/2008)

• Making the Case for National Screening - AASLD (10/2008)

• Epidemiology of Hepatitis B - NIH Consensus Development Conference: Management of Hepatitis B (10/2008)

• Management Approach of a NASH Patient Handling Persistent Transaminitis in HASH on Standard Therapy - 2nd St. Luke's International Liver Conference(1/2009)

• Management of HCV in Liver Transplantation - 19th Conference of APASL (2/2009)


of 32

• Complications of Cirrhosis - CLDF Lecture Series (7/2010)

• Hepatitis B Infection in Asian Americans - MN Viral Hepatitis Symposium (7/2010)

• The Clinical Implications of Managing Cirrhotics - CLD Lecture Series (8/2010)

• Economic Impact of Critical Care in Patients with Cirrhosis in the US - AASLD (10/2010)

• End Points for ACLF Studies - First Joint Workshop Special Interest Group of Acute on Chronic Liver Failure and EASL--#Chronic Liver Failure (10/2010)

• Predicting Outcomes of Cirrhotics Undergoing Surgery and Awaiting Transplant (11/2010)

• The Clinical Implications of Managing Cirrhotics - International Symposium on Cirrhosis (1/2011)

• Treatment of Hepatitis C in 2011: A US Perspective - Japanese Association of Liver Disease (2/2011)

• Global Burden of Liver Disease - Asia-Pacific Association for Study of the Liver (3/2011)

• Management of HBeAg#Negative Hepatitis B - Digestive Disease Week 2011 (5/2011)

• Burden of HBV and HCV Disease - CDC/AASLD Single Topic Conference (6/2011)

• Principles of Clinical Research - Samsung#Mayo Gastroenterology Symposium (6/2011)

• Hepatitis B Update - Korean American Medical Association (9/2011)

• Burden of Chronic Viral Hepatitis - MN Viral Hepatitis Symposium (10/2011)

• Cost Effectiveness to Transplantation - Transplant Summit (10/2011)

• Non-alcoholic Steatohepatitis Acute Liver Failure - Liver Conference (12/2011)

• Renal Injuries Before and After Liver Transplantation - Seoul Transplant Surgery Symposium (12/2011)

• Cohort and Case-control Studies - AASLD/APASL/EASL (2/2012)

• Hepatitis B Treatment, When to Start and Stop Who to Transplant First, Going Beyond MELD - Fortis International Liver Summit (3/1993)

• Surveillance for Hepatocellular Carcinoma - India National Association for Study of the Liver (3/2012)

• The Disturbing Epidemiology of Alcohol Associated Liver Disease - DDW 2012 (5/2012)

• Renal Injury - DDW 2012 (5/2012)

• Universal Induction Therapy in Liver Transplantation - ILTS 2012 (5/2012)

• Emerging Therapies for Viral Hepatitis - Midwest Viral Hepatitis Conference (5/2012)

• Comparative Effectiveness of Antivirals on HCC - The Liver Meeting 2012, Federal Focus # AASLD/NCI, Viral Hepatitis and Drug Discovery in HCC (11/2012)

• Towards Cost#effective Care in Special Populations - American Association for the Study of Liver Diseases, Hepatitis Single Topic Conference (2/2013)

• The Economics of Hepatitis C Testing, Care, and Treatment - HCV Testing Recommendations Implementation Panel: Healthcare Payers (3/2012)

• Research Methodology Workshop: Translational Research 101 - APASL Liver Week (6/2013)

• NAFLD/NASH: Therapeutic Options - St. Luke's 4th Liver and 2nd Gastroenterology International Symposium (6/2013)

• Clinical Challenge: Management of Chronic Hepatitis C in Special Populations (HIV coinfection, cirrhosis, hemoglobinopathy, post--#transplant, treatment failure)- St. Luke's 4th Liver and 2nd Gastroenterology International Symposium (6/2013)

• Coagulation and Anti-#coagulation in Liver Disease - St. Luke's 4th Liver and 2nd Gastroenterology International Symposium (6/2013)

• AASLD Policy to Control HCC - The 4th Asia-Pacific Primary Liver Cancer Expert Meeting (7/2013)

• Understanding Clinical Epidemiology and Biostatistics - American Association for the Study of Liver Diseases (10/2013)

• What is New with Viral Hepatitis: An Update on Hepatitis C - University of Rochester (10/1999)

• Survival Models for Liver Transplant Recipients - Outcome of Hospitalization Care of Hepatitis C in the United States - Mount Sinai Hospital (4/2000)

• Hepatitis B in Asian Americans - Cleveland Clinic (1/2008)

• Hyponatremia and Liver Transplantation - Beth Israel (10/2008)

• Portal Hypertension and Hyponatremia - University of Toronto School of Medicine (3/2009)

• Comparative Effectiveness Research - Medical Grand Rounds - Chung Ang University (6/2011)


of 32

• Update on Hepatitis B - Baylor College of Medicine (3/2012)

• Going beyond MELD - Postgraduate Institute (5/2012)

• New Paradigm in Hepatitis B - Ulsan University (6/2012)

• Hepatic Encephalopathy - University of Maryland (10/2012)

• Hepatitis B and Hepatocellular Carcinoma - Chulalongkorn University (3/2013)

• The Kidney in End#stage Liver Disease - Northwestern University (6/2013)

• Circulatory and Renal Pathophysiology in Liver Transplantation - University of Barcelona (10/2013)

• Economics of Viral Hepatitis - University of Pennsylvania (3/2014)

• Liver and Kidney Transplantation - Scripps Institute (5/2014)

• Non-#invasive Measures of Liver Fibrosis (4/2014)

• Liver and Kidney Transplantation - University of Utah (11/2014)

• Liver and Kidney Transplantation - Tampa General Hospital (11/2014)

• Hepatitis B - University of Pittsburgh (5/2015)

w. ray kim - stanford university

Documents